Skip to main content
PLOS Genetics logoLink to PLOS Genetics
. 2021 Oct 29;17(10):e1009871. doi: 10.1371/journal.pgen.1009871

Metabolic flux from the Krebs cycle to glutamate transmission tunes a neural brake on seizure onset

Jiwon Jeong 1, Jongbin Lee 1, Ji-hyung Kim 1, Chunghun Lim 1,*
Editor: Gaiti Hasan2
PMCID: PMC8555787  PMID: 34714823

Abstract

Kohlschütter-Tönz syndrome (KTS) manifests as neurological dysfunctions, including early-onset seizures. Mutations in the citrate transporter SLC13A5 are associated with KTS, yet their underlying mechanisms remain elusive. Here, we report that a Drosophila SLC13A5 homolog, I’m not dead yet (Indy), constitutes a neurometabolic pathway that suppresses seizure. Loss of Indy function in glutamatergic neurons caused “bang-induced” seizure-like behaviors. In fact, glutamate biosynthesis from the citric acid cycle was limiting in Indy mutants for seizure-suppressing glutamate transmission. Oral administration of the rate-limiting α-ketoglutarate in the metabolic pathway rescued low glutamate levels in Indy mutants and ameliorated their seizure-like behaviors. This metabolic control of the seizure susceptibility was mapped to a pair of glutamatergic neurons, reversible by optogenetic controls of their activity, and further relayed onto fan-shaped body neurons via the ionotropic glutamate receptors. Accordingly, our findings reveal a micro-circuit that links neural metabolism to seizure, providing important clues to KTS-associated neurodevelopmental deficits.

Author summary

Kohlschütter-Tönz syndrome (KTS) is a neurodevelopmental disorder linked to two distinct genomic loci encoding the citrate transporter SLC13A5 and synaptic protein ROGDI, respectively. An early-onset seizure is the most prominent neurological symptom in KTS patients, yet how these genes contribute to the control of seizure susceptibility remains poorly understood. Our study establishes behavioral models of seizure in Drosophila mutants of KTS-associated genes and demonstrates a genetic, metabolic, and neural pathway of seizure suppression. We discover that the metabolic flux of the Krebs cycle to glutamate biosynthesis plays a critical role in scaling seizure-relevant glutamate transmission. We further map this seizure-suppressing pathway to a surprisingly small number of glutamatergic neurons and their ionotropic glutamate transmission onto a key sleep-promoting locus in the adult fly brain. Given that the excitatory amino acid glutamate is considered a general seizure-promoting neurotransmitter, our findings illustrate how glutamatergic transmission can have opposing effects on seizure susceptibility in the context of a micro-neural circuit, possibly explaining drug-resistant epilepsy. This seizure-suppressing locus in the Drosophila brain is also implicated in metabolism, circadian rhythms, and sleep, revealing the conserved neural principles of their intimate interaction with epilepsy across species.

Introduction

Kohlschütter-Tönz syndrome (KTS) is a genetic disorder that manifests as developmental abnormalities such as tooth dysplasia, intellectual disability, and early-onset epileptic encephalopathy [1]. Whole-exome sequencing has revealed molecular lesions that are associated with KTS, identifying mutations in two independent loci, ROGDI [26] and SLC13A5 (solute carrier family 13 member 5) [710], as the genetic causes of KTS. Homologs of the two KTS-associated genes are relatively well conserved across different species. Accordingly, animal models for ROGDI or SLC13A5 serve as essential genetic resources to elucidate the physiological function of the gene products and their mechanisms underlying the KTS pathogenesis.

SLC13A5 is a plasma membrane transporter of intermediates of the tricarboxylic acid (TCA) cycle, also known as the citric acid cycle or Krebs cycle, that displays the highest affinity for citrate [11,12]. The Drosophila homolog of SLC13A5 is I’m not dead yet (Indy), named for the long lifespan of loss-of-function mutants [13], although the longevity phenotype might be sensitive to genetic background or calorie intake [1416]. As expected based on its citrate-transporter activity, loss of Indy function phenocopies physiological changes in calorie-restricted animals, including low body weight, low triglyceride levels, and high sensitivity to starvation [16,17]. In fact, calorie restriction down-regulates Indy expression in Drosophila, whereas Indy mutants display low expression levels of insulin-like peptides [16]. Mitochondrial physiology is also altered in Indy mutant flies (i.e., increased mitochondrial biogenesis, decreased electron transport chain function), likely via a mechanism dependent on peroxisome proliferator-activated receptor gamma coactivator-1α [1618].

Consistent with this, depletion of an INDY homolog in worms extends life span and leads to a “lean” phenotype, likely via an AMPK-dependent pathway [19,20]. In mice, genomic deletion of the mammalian Indy homolog (mIndy), as well as liver-specific mINDY depletion, results in a protection against obesity, fatty liver, and insulin resistance upon feeding a high-fat diet—metabolic conditions comparable to those observed in flies and worms [2123]. Notably, gene expression profiles in mIndy mutant mice largely resemble those in calorie-restricted animals [21]. mIndy expression in mice is also altered by metabolic challenge (e.g., starvation, fatty-liver disease conditions), and distinct transcription factors (e.g., CREB, STAT3, ARNT, PXR) have been implicated in this adaptive regulation of mIndy transcription [2427].

While there is abundant genetic evidence for Indy function in metabolism [2830], much less is known about the function of ROGDI homologs. A Drosophila genetic screen initially identified rogdi as one of the genes associated with memory formation [31] and emerging evidence suggests a role of ROGDI homologs in neurons [3,5,32,33]. The crystal structure of human ROGDI protein displays a leucine-zipper-like four-helix bundle and a characteristic beta-sheet domain, hinting at how KTS-associated ROGDI mutations would impair the overall structure and stability of the encoded protein [34]. Nonetheless, how metabolic or neural functions of the KTS-associated gene products are coupled to the neurodevelopmental pathogenesis underlying KTS remains elusive.

In this study, we demonstrate that Drosophila mutants of KTS-associated genes display seizure-like behaviors. We further provide compelling evidence that Indy links the flux of the TCA cycle in a specific set of glutamatergic neurons to the scale of their neural transmission to achieve metabolic control of seizure susceptibility. Given that early-onset seizure is one of the most prominent symptoms in KTS patients, our findings provide important insights into the neural mechanism responsible for the development of KTS.

Results

Indy acts in glutamatergic neurons to suppress bang-induced seizure

The early-onset seizure is one of the most prominent neurological symptoms observed in KTS patients. We hypothesized that Drosophila mutants of KTS-associated genes might recapitulate genetic conditions in KTS patients and display seizure-like behaviors. After a mechanical stimulus (vortexing for 25 s), wild-type flies immediately recovered a normal posture and resumed their locomotion (Fig 1A). By contrast, Indy mutants homozygous or trans-heterozygous for loss-of-function alleles exhibited “bang-induced” seizure-like behaviors (e.g., severe wing-flapping, abdominal contractions, leg-twitching, or failure to stand upright), as reflected in a high seizure index and prolonged recovery time (Fig 1B and S1 Movie). The bang-sensitive seizure (BSS) phenotypes in Indy mutants were comparable to those observed in other seizure mutants, such as easily shocked or slamdance but weaker than bang senseless mutants [3537] (S1A Fig). Moreover, Indy mutant seizure displayed transient resistance to the second mechanical stimulus after the first BSS (S1B Fig), indicating the seizure threshold shifts during the refractory period as observed in other bang-sensitive mutants [38]. To map a neural locus responsible for Indy mutant BSS, we silenced Indy expression by overexpressing an RNA interference (RNAi) transgene in select groups of cells and examined subsequent effects on BSS (S2A Fig). INDY depletion in vesicular glutamate transporter (VGlut)-expressing neurons phenocopied BSS in Indy mutants (Fig 1C), whereas the Indy RNAi in other groups of neurons defined by their specific neurotransmitters (e.g., GABAergic, cholinergic, or dopaminergic neurons) did not induce BSS (S2B Fig). The INDY-depletion phenotypes were confirmed by independent Indy RNAi transgenes (i.e., IndyRNAi #2, #3, and #4), possibly excluding off-target effects (S2C Fig). We generated a mutant INDY transgene that harbored a KTS-associated allele (S3 Fig, INDYT245M) and expressed mutant INDY proteins with no citrate transporter activity [79,39]. Overexpression of INDYT245M in VGlut-expressing neurons similarly induced BSS in a wild-type Indy background (Fig 1C). Moreover, transgenic expression of wild-type Indy cDNA in VGlut-expressing neurons was sufficient to rescue BSS in Indy mutants (Fig 1D). These results suggest that Indy function in glutamatergic neurons is necessary and sufficient for seizure suppression. We further found that rogdi mutants displayed BSS comparably to Indy mutants (S4A Fig), and its seizure-suppressor function was similarly mapped to glutamatergic neurons (S4B–S4D Fig). Nevertheless, our subsequent analyses focused on elucidating Indy-dependent mechanisms of seizure control since the molecular function of ROGDI has been poorly defined.

Fig 1. Loss of Indy function in glutamatergic neurons induces BSS.

Fig 1

(A) Experimental design for the quantitative analysis of bang-induced seizure-like behaviors in Drosophila. A group of flies (n = 5) was vortexed for 25 s, after which post-stimulus responses were video recorded. Seizure-like behaviors, including wing-flapping and abdomen-twitching, were scored in individual flies. (B) Quantitative analyses of BSS in Indy mutants homozygous or trans-heterozygous for loss-of-function alleles. A seizure index was calculated as the ratio of the number of BSS-positive flies to the total number of flies tested in each experiment (n = 20; 5 flies per group × 4 groups per experiment) and averaged from three independent experiments. Recovery time was calculated individually for BSS-positive flies as the latency to normal posture after vortexing and was averaged for each genotype (n = 7–29 flies). Percent seizure was calculated as the percentage of BSS-positive flies per genotype at each second after vortexing (n = 60 flies; 20 flies per experiment × 3 experiments). Data represent means ± SEM. n.s., not significant; **P < 0.01, ***P < 0.001, as determined by one-way ANOVA with Holm-Sidak’s multiple comparisons test (seizure index) or by Kruskal Wallis test with Dunn’s multiple comparisons test (recovery time). (C) Silencing of Indy function in glutamatergic neurons by transgenic overexpression of IndyRNAi or KTS-associated IndyT245M is sufficient to induce BSS. Quantitative analyses of BSS in individual flies were performed as described above. Data represent means ± SEM (seizure index, n = 60 flies in 3 independent experiments; recovery time, n = 5–39 flies). ***P < 0.001, as determined by one-way ANOVA with Holm-Sidak’s multiple comparisons test. (D) Transgenic overexpression of wild-type INDY in glutamatergic neurons rescues BSS in Indy mutants. Data represent means ± SEM (seizure index, n = 60 flies in 3 independent experiments; recovery time, n = 5–33 flies). n.s., not significant; **P < 0.01, ***P < 0.001, as determined by two-way ANOVA with Holm-Sidak’s multiple comparisons test.

Down-regulation of glutamate transmission induces BSS in Indy mutants

To determine if glutamate transmission actually contributes to BSS phenotypes in Indy mutants, we genetically manipulated the expression of VGLUT, a vesicular transporter that incorporates glutamate into synaptic vesicles [40], and examined subsequent effects on Indy-dependent BSS. The heterozygosity of VGlut did not induce seizure-like behaviors in wild-type flies (Fig 2A); however, it substantially increased seizure susceptibility in Indy heterozygous mutants. VGLUT overexpression in glutamatergic neurons partially but significantly rescued BSS phenotypes in INDY-depleted flies (Fig 2B). It has been shown that VGLUT overexpression increases synaptic vesicle size in larval motor neurons and their spontaneous release of glutamate at the larval neuromuscular junction [4042], whereas it could lead to neurodegeneration in a cell type-specific manner [42,43]. Nonetheless, no gross effects of VGLUT overexpression were detected on the seizure susceptibility in wild-type flies (Fig 2B). We further mapped two glutamate receptors, N-methyl-D-aspartic acid receptors (Nmdar1 and Nmdar2) and glutamate-gated chloride channel (GluClα), that mediate Indy-dependent BSS in trans-heterozygous mutants (Fig 2C). However, hemizygous Nmdar2 mutants exhibited significant BSS even in a wild-type Indy background. These genetic interactions suggest that down-scaling of glutamate transmission via the ionotropic glutamate receptors may underlie BSS phenotypes in Indy mutants.

Fig 2. Down-regulation of glutamatergic transmission is responsible for Indy-dependent BSS.

Fig 2

(A) Heterozygosity of VGlut induces BSS in heterozygous Indy mutants. Quantitative analyses of BSS in individual flies were performed as described in Fig 1. Data represent means ± SEM. ***P < 0.001, as determined by one-way ANOVA with Holm-Sidak’s multiple comparisons test (seizure index, n = 55–60 flies in 3 independent experiments) or by Welch’s ANOVA with Dunnett’s multiple comparisons test (recovery time, n = 7–32 flies). (B) Overexpression of wild-type VGLUT suppresses BSS induced by transgenic depletion of INDY in glutamatergic neurons. Data represent means ± SEM (seizure index, n = 55–60 flies in 3 independent experiments; recovery time, n = 5–34 flies). n.s., not significant; *P < 0.05, **P < 0.01, ***P < 0.001, as determined by one-way ANOVA with Holm-Sidak’s multiple comparisons test. (C) Heterozygosity of ionotropic glutamate receptor Nmdar or GluClα induces BSS in heterozygous Indy mutants. Significant Indy x glutamate receptor interaction effects on seizure index (P = 0.0047 for Nmdar1; P = 0.0023 for Nmdar2; P = 0.0009 for GluClα) and recovery time (P = 0.0136 for Nmdar2; P = 0.0049 for GluClα) were detected by two-way ANOVA. Data represent means ± SEM (seizure index, n = 60 flies in 3 independent experiments; recovery time, n = 2–37). *P < 0.05, **P < 0.01, ***P < 0.001, as determined by Holm-Sidak’s multiple comparisons test.

A metabolic link between the TCA cycle and glutamate transmission underlies Indy-dependent seizure suppression

Two classes of presynaptic neurons—glutamatergic and GABAergic—are intrinsically coupled to astrocytes via the glutamate/GABA-glutamine cycle, mediating excitatory and inhibitory transmissions, respectively. An imbalance in their activity is associated with neurological disorders, including a seizure [4446]. In contrast to the mammalian central nervous system, acetylcholine is the primary excitatory neurotransmitter in the fly brain whereas glutamate plays this role at the neuromuscular junction [4749]. Nonetheless, our genetic evidence indicated that low glutamate transmission likely induced seizure-like behaviors in Indy mutants. We thus examined if the loss of Indy function impaired the biosynthesis of glutamate or GABA. Our quantitative assessment of free amino acids revealed that glutamate levels were substantially reduced in Indy mutants (Fig 3A). In contrast, no significant differences in GABA levels were detected between wild-type and Indy mutant flies. Considering that glutamate dehydrogenase (GDH) mediates the interconversion of glutamate and α-ketoglutarate—one of the TCA cycle intermediates (Fig 3B)—we reasoned that loss of INDY-dependent import of extracellular citrate might limit glutamate biosynthesis via the TCA cycle.

Fig 3. Indy-dependent BSS involves a metabolic link between the TCA cycle and glutamate transmission.

Fig 3

(A) Indy mutants display low levels of free glutamate that are rescued by oral administration of α-ketoglutarate (AKG). Flies were fed control or AKG-containing food (20 mM) for 3 d before harvesting. Free amino acids in whole-body extracts were quantified using ion-exchange chromatography. Relative levels of glutamate and GABA were calculated by normalizing to glycine levels. A significant Indy x AKG interaction effect on glutamate levels (P = 0.0006) was detected by two-way ANOVA. Data represent means ± SEM (n = 3–4). n.s., not significant; ***P < 0.001, as determined by Holm-Sidak’s multiple comparisons test. (B) Glutamate biosynthesis via the TCA cycle. IDH, isocitrate dehydrogenase; GDH, glutamate dehydrogenase; GPT, glutamate-pyruvate transaminase; GOT, glutamate-oxaloacetate transaminase. (C) Oral administration of the GDH inhibitor epigallocatechin gallate (EGCG) exaggerates BSS phenotypes in Indy mutants. Flies were fed control or EGCG-containing food (5 mg/ml) for 3 d before the BSS assessment. Quantitative analyses of BSS in individual flies were performed as described in Fig 1. Two-way ANOVA detected a significant Indy x EGCG interaction effect on seizure index (P = 0.0025). Data represent means ± SEM (seizure index, n = 58–60 flies in 3 independent experiments; recovery time, n = 5–43 flies). n.s., not significant; **P < 0.01, ***P < 0.001, as determined by Holm-Sidak’s multiple comparisons test. (D) Idh3g heterozygosity induces BSS phenotypes in heterozygous Indy mutants. Significant Indy x Idh3g interaction effects on seizure index (P = 0.0002 by two-way ANOVA) and recovery time (P = 0.0086 by Aligned ranks transformation ANOVA) were detected. Data represent means ± SEM (seizure index, n = 50–60 flies in 3 independent experiments; recovery time, n = 8–33 flies). ***P < 0.001, as determined by Holm-Sidak’s multiple comparisons test (seizure index) or by Wilcoxon rank sum test (recovery time). (E and F) Oral administration of AKG rescues BSS phenotypes in Indy mutants. Flies were fed control or AKG-containing food (20 mM) for 3 d before the BSS assessment. Data represent means ± SEM (seizure index, n = 50–119 flies in 3 independent experiments; recovery time, n = 10–56 flies). n.s., not significant; *P < 0.05, **P < 0.01, as determined by one-way ANOVA with Holm-Sidak’s multiple comparisons test (seizure index), by Welch’s ANOVA with Dunnett’s T3 multiple comparisons test (E, recovery time), or by Kruskal-Wallis test with Dunn’s multiple comparisons (F, recovery time).

To validate this hypothesis, we fed the GDH inhibitor, epigallocatechin gallate [50], to adult flies and tested its effects on BSS phenotypes. Pharmacological inhibition of GDH robustly increased both seizure index and recovery time after BSS in Indy mutants, but it did not induce BSS in wild-type flies (Fig 3C). Similar results were obtained using another GDH inhibitor (i.e., diethylstilbestrol), excluding possible off-target effects (S5 Fig). Accordingly, these data suggest that GDH-mediated metabolic flux is limiting for seizure suppression, particularly in the context of Indy deficiency. To further examine the involvement of the TCA cycle in seizure suppression, we genetically manipulated isocitrate dehydrogenase 3 (IDH3), a hetero-tetrameric enzyme that converts isocitrate into α-ketoglutarate in the rate-limiting step in the TCA cycle (Fig 3B). Heterozygosity of the Idh3g mutant allele induced BSS in Indy heterozygous mutants, but not in wild-type flies (Fig 3D). In addition, RNAi-mediated depletion of individual IDH3 subunit proteins in wild-type glutamatergic neurons alone was sufficient to induce BSS (S6 Fig). These lines of pharmacological and genetic evidence indicate that reducing the metabolic flux from the TCA cycle to glutamate biosynthesis may down-scale seizure-suppressing glutamate transmission, thereby causing BSS phenotypes in Indy mutants.

We further hypothesized that dietary supplements of TCA cycle intermediates should compensate for the genetic deficits in flies with loss of Indy function and rescue their BSS phenotypes. Oral administration of α-ketoglutarate indeed ameliorated seizure phenotypes in Indy mutants in a dose-dependent manner (Fig 3E). Moreover, α-ketoglutarate supplementation restored glutamate levels in Indy mutants to wild-type levels (Fig 3A). Unexpectedly, we found that α-ketoglutarate supplementation induced a dose-dependent increase in seizure index, but not recovery time, in wild-type flies (Fig 3F). A possible explanation for this observation is that an excess of α-ketoglutarate may lead to an imbalance in the metabolic flux between the TCA cycle and glutamate in wild-type flies, thereby lowing the threshold for seizure initiation. Alternatively, surplus α-ketoglutarate may deplete synaptic vesicles containing glutamate by promoting their fusion with the synaptic membrane [51] (see Discussion).

A pair of glutamatergic neurons mediates Indy-dependent seizure suppression

Genetic and biochemical analyses in Indy mutants revealed the contribution of low glutamate transmission to their seizure phenotypes. We found that daily locomotor activity was reduced in Indy mutants, but their waking activity (i.e., activity count per minute awake) was indistinguishable from wild-type control (S7A Fig). Moreover, wild-type and Indy mutants displayed similar climbing activities in a negative geotaxis assay (S7B Fig). We thus reasoned that the glutamate transmission in Indy mutants might not be limiting for general motor function as reported previously [13,16,5254], but a subset of the glutamatergic neurons would be somehow sensitized to loss of Indy function for seizure control. Our transgenic mapping of the Indy RNAi phenotypes actually identified a very small group of neurons expressing the neuropeptide leucokinin [55] (hereafter, LK neurons) as a neural locus important for Indy-dependent seizure suppression (Figs 4A and S2B). Introduction of a temperature-sensitive Gal80 transgene allowed us to turn off the Gal4-driven expression of the Indy RNAi transgene at low temperature (i.e., 21°C) but silence endogenous Indy expression in LK neurons at high temperature (i.e., 29°C). The conditional RNAi confirmed that Indy was necessary in adult LK neurons for seizure suppression (S8 Fig). Conversely, transgenic expression of the wild-type Indy cDNA in LK neurons was sufficient to rescue BSS in Indy mutants (Fig 4B).

Fig 4. A pair of LK neurons mediates Indy-dependent BSS.

Fig 4

(A) A glutamatergic transgene specifically targets a pair of LHLK neurons among LK neurons. LK neurons in the adult brain (LHLK and SELK) and ventral nerve cord (ABLK) were visualized by transgene expression of nuclear GFP (nlsGFP). The VGlut-Gal80 transgene suppressed GFP expression only in LHLK neurons. Representative confocal images of each genotype were shown. (B) INDY overexpression in LK neurons is sufficient to rescue BSS phenotypes in Indy mutants. Quantitative analyses of BSS in individual flies were performed as described in Fig 1. Data represent means ± SEM. n.s., not significant; *P < 0.05, **P < 0.01, ***P < 0.001, as determined by two-way ANOVA with Holm-Sidak’s multiple comparisons test (seizure index, n = 60 flies in 3 independent experiments) or by Aligned ranks transformation ANOVA with Wilcoxon rank sum test (recovery time, n = 9–29). (C) INDY depletion in a pair of LHLK neurons is necessary for BSS phenotypes in Indy RNAi flies. LK neuron-specific expression of the Indy RNAi transgene was inhibited specifically in LHLK neurons by the VGlut-Gal80 transgene. Data represent means ± SEM (seizure index, n = 55–60 flies in 3 independent experiments; recovery time, n = 3–28 flies). n.s., not significant; **P < 0.01, ***P < 0.001, as determined by one-way ANOVA with Holm-Sidak’s multiple comparisons test.

LK neurons can be divided into three groups based on their neuroanatomical positions in the adult brain and ventral nerve cord [56]. These include lateral horn LK (LHLK), subesophageal ganglion LK (SELK), and abdominal LK (ABLK) neurons (Fig 4A). To determine which subset of LK neurons contributed to Indy-dependent seizure suppression, we employed additional Gal80 transgenes that were constitutively expressed in specific subgroups of LK neurons and inhibited Gal4 activity to restrict their expression of the Indy RNAi transgene. This intersectional strategy revealed that ABLK neurons in the ventral nerve cord, targeted by tsh-Gal80 [57], were dispensable for BSS control (Fig 4A and 4C). In contrast, INDY depletion in a single pair of LHLK neurons, specifically targeted by a glutamatergic VGlut-Gal80 transgene, was necessary to induce BSS (Fig 4A and 4C).

A previous study suggested that LK neurons are unlikely glutamatergic [56]. However, we found additional evidence supporting that LHLK neurons indeed express the glutamatergic marker VGlut. LK neuron-specific expression of B3 recombinase led to the genomic excision of VGlut coding sequence flanked by the B3 recombination target sites from the genome-edited VGlut allele (B3RT-VGlut-B3RT-LexA) [58], thereby driving the downstream expression of a transgenic LexA driver only in VGlut-expressing LK neurons (S9A Fig). Assessment of the transgene expression in the adult fly brain revealed that LHLK neurons, but not SELK neurons, expressed the VGlut-derived LexA (S9B Fig), indicating VGlut expression only in LHLK neurons. Given these observations, we asked whether Indy controls the glutamate transmission from LHLK neurons for seizure suppression. A transgenic fluorescence sensor for detecting synaptic release of glutamate [59] validated that INDY depletion in LHLK neurons lowered the levels of glutamate release (Fig 5A). Transgenic overexpression of wild-type VGLUT not only rescued the glutamate transmission in INDY-depleted LHLK neurons (Fig 5A) but also suppressed their BSS phenotypes (Fig 5B). These observations indicate that the glutamate transmission from INDY-depleted LHLK neurons is likely limiting for seizure suppression.

Fig 5. LK neurons suppress seizures via metabolic control of glutamate transmission.

Fig 5

(A) Overexpression of wild-type VGLUT rescues low glutamate levels in INDY-depleted LHLK neurons. The fluorescent glutamate sensor, iGluSnFR, was co-expressed with IndyRNAi and wild-type VGLUT transgenes in LK neurons. Fluorescence images of LHLK neurons in dissected brains were recorded using photoactivated localization microscopy and analyzed using ZEN software. Relative fluorescence was calculated by normalizing to backgrounds and was averaged for each genotype (n = 19–38). A significant Indy x VGlut interaction effect on the iGluSnFR signal (P < 0.0001) was detected by Aligned ranks transformation ANOVA. Error bars indicate SEM. n.s., not significant; ***P < 0.001, as determined by Wilcoxon rank sum test. (B) Overexpression of wild-type VGLUT suppresses BSS caused by the loss of Indy function in LK neurons. Quantitative analyses of BSS in individual flies were performed as described in Fig 1. Data represent means ± SEM (seizure index, n = 56–60 flies in 3 independent experiments; recovery time, n = 3–37 flies). **P < 0.01, ***P < 0.001, as determined by one-way ANOVA with Holm-Sidak’s multiple comparisons test. (C) Oral administration of AKG rescues low glutamate levels in INDY-depleted LHLK neurons. Transgenic flies were fed control or AKG-containing food (20 mM) for 3 d before live-brain imaging. A significant Indy x AKG interaction effect on the iGluSnFR signal (P = 0.0014) was detected by Aligned ranks transformation ANOVA. Data represent means ± SEM (n = 16–24). n.s., not significant; ***P < 0.001, as determined by Wilcoxon rank sum test. (D) Oral administration of AKG suppresses BSS caused by the loss of Indy function in LK neurons. Data represent means ± SEM (seizure index, n = 60 flies in 3 independent experiments; recovery time, n = 3–13 flies). n.s., not significant; *P < 0.05, as determined by one-way ANOVA with Holm-Sidak’s multiple comparisons test.

To validate the Indy-relevant link between the TCA cycle and glutamate transmission in seizure-suppressing LHLK neurons, we performed two additional experiments. First, oral administration of α-ketoglutarate partially but significantly restored the glutamate transmission in INDY-depleted LHLK neurons (Fig 5C) and suppressed the BSS phenotypes induced by loss of Indy function in LK neurons (Fig 5D). Second, IDH3 depletion in LK neurons was sufficient to induce BSS (S10 Fig), phenocopying the seizure induction by the pan-glutamatergic IDH3 depletion (S6 Fig). Taken together, these results demonstrate that a pair of glutamatergic LK neurons mediates Indy-dependent seizure suppression.

LK neuron activity gates the behavioral output from seizure initiation

LK signaling has been implicated in neural physiology and behaviors relevant to metabolism in Drosophila [55,57,6064]. It has also been shown that Indy mutant flies physiologically mimic calorie-restricted animals and exhibit low fat levels [16], raising the possibility that energy deficiency might underlie Indy mutant seizure. Nonetheless, we found some evidence against this idea. First, a lipid-rich diet did not rescue Indy mutant seizures while significantly suppressing BSS phenotypes in other seizure mutants [37] (S11A Fig). We note, however, the lipid-rich diet did not rescue low glucose levels in Indy mutants (S11B Fig). Second, LK neuron-specific loss of Indy function did not affect the baseline levels of triglyceride and glucose (S11C Fig) and the corresponding seizure was insensitive to the lipid-rich supplement (S11D Fig). Finally, hypomorphic mutants of Lk and Lk receptor (Lkr) genes did not exhibit any detectable phenotypes in seizure index under our experimental conditions (S12 Fig). We thus reasoned that LK neuron activity, but not the LK signaling or metabolism per se, might be critical for Indy-dependent seizure suppression. Live-brain imaging revealed that INDY depletion reduced the baseline levels of intracellular Ca2+ in LHLK neurons (Fig 6A), possibly reflecting their low activity. We asked whether transgenic manipulations of LK neuron activity could either suppress or mimic INDY-depletion phenotypes in BSS.

Fig 6. LK neuron activity gates the behavioral output from seizure initiation.

Fig 6

(A) INDY depletion reduces intracellular Ca2+ levels in LHLK neurons. The codon-optimized calcium sensor, jGCaMP7f, was co-expressed with IndyRNAi in LK neurons. The fluorescence signal in LHLK neurons was analyzed as described in Fig 5A. Data represent means ± SEM (n = 11–12). ***P < 0.001, as determined by Mann-Whitney test. (B) Experimental design for optogenetic manipulations of neural activity during the assessment of BSS. (C) Optogenetic excitation of LK neurons substantially suppresses BSS in INDY-depleted flies. Transgenic flies were crossed and kept in constant darkness. The mechanical stimulus was given under blue light (no excitation) or red light (excitation by CsChrimson), and BSS phenotypes were then assessed under blue light. Quantitative analyses of BSS in individual flies were performed as described in Fig 1. Data represent means ± SEM (seizure index, n = 56–60 flies in 3 independent experiments; recovery time, n = 4–33 flies). n.s., not significant; ***P < 0.001, as determined by two-way ANOVA with Holm-Sidak’s multiple comparisons test. (D) Optogenetic silencing of glutamatergic LK neurons induces BSS in a wild-type background. The mechanical stimulus was given under blue light (no silencing) or amber light (silencing by eNpHR). Data represent means ± SEM (seizure index, n = 59–60 flies in 3 independent experiments; recovery time, n = 6–52 flies). n.s., not significant; ***P < 0.001, as determined by two-way ANOVA with Holm-Sidak’s multiple comparisons test.

To this end, optogenetic transgenes were combined with different genetic tools to excite or silence LK neuron activity only during seizure induction for the assessment of their effects on BSS (Fig 6B). Transgenic flies expressing CsChrimson [65] were exposed to red light to transiently excite LK neurons during a mechanical stimulus. This manipulation significantly suppressed BSS phenotypes in Indy RNAi flies (Fig 6C), whereas the light transition per se negligibly affected Indy-dependent seizure. These observations validate that Indy RNAi phenotypes are readily reversible in adult LK neurons within a range of seconds, excluding the possibility that any long-term effects of INDY depletion on neuronal development or metabolic stress contribute to the seizure control. We consistently found that amber light-dependent silencing of LHLK neurons by the eNpHR transgene [66] was sufficient to induce BSS, even in a wild-type background (Fig 6D). These results demonstrate that LK neuron activity inversely correlates with seizure susceptibility. Nonetheless, the optogenetic inhibition of LK neuron activity alone did not trigger seizure-like behaviors in the absence of a mechanical stimulus (S13 Fig). We reason that this neural locus may not initiate seizure-like behaviors but inhibit the behavioral output from an as-yet-unmapped seizure-initiating locus in the adult Drosophila brain.

NMDA receptors in dorsal fan-shaped body neurons act downstream of LHLK neurons to suppress BSS

Although the implication of LK-LKR signaling in Indy-dependent seizure was not evident, we reasoned that LKR-expressing neurons could still act downstream of LHLK neurons via the seizure-suppressing glutamate transmission. It has been shown that LKR neurons are present in distinct parts of the adult fly brain, including the pars intercerebralis, ellipsoid body, and fan-shaped body (FSB) [55,57,60]. Also, our transgenic expression of the GFP-fused synaptotagmin 1 revealed LHLK projections in the LH and FSB (Fig 7A). We thus employed a dorsal FSB (dFSB)-specific Gal4 driver (i.e., R23E10-Gal4) to examine whether glutamate receptors expressed in dFSB neurons contribute to the susceptibility of BSS. We indeed found that dFSB-specific depletion of NMDAR2 was sufficient to cause BSS phenotypes, comparable to the high seizure index and long recovery time observed in Nmdar2 mutants (Fig 7B). Neither electrical silencing of dFSB neurons by the inwardly rectifying Kir2.1 channel [67] nor blocking their synaptic transmission by tetanus toxin light chain (TNT) [68] significantly affected seizure index; however, both the transgenic manipulations lengthened the recovery time in BSS-positive animals (Fig 7C). These data together map the metabolic control of seizure onset to the glutamate transmission between LHLK and dFSB neurons and suggest that the subsequent output of dFSB neurons may govern the duration of seizure-like behaviors.

Fig 7. NMDA receptors in dorsal fan-shaped body neurons relay seizure-suppressing glutamate transmission.

Fig 7

(A) Representative confocal images of dendrites (DenMark, red) and axonal projections (syt.eGFP, green) from LHLK neurons (top) and mGFP expression from dFSB-specific R23E10-Gal4 driver (bottom) in the adult fly brain. (B) Depletion of NMDA receptors in dFSB neurons induces BSS. Quantitative analyses of BSS in individual flies were performed as described in Fig 1. Data represent means ± SEM. **P < 0.01, ***P < 0.001, as determined by one-way ANOVA with Holm-Sidak’s multiple comparisons test (seizure index, n = 60 in 3 independent experiments) or by Welch’s ANOVA with Dunnett’s multiple comparisons test (recovery time, n = 3–34). (C) Genetic silencing of dFSB neurons lengthens recovery time after BSS. Data represent means ± SEM. n.s., not significant; *P < 0.05, ***P < 0.001, as determined by one-way ANOVA with Holm-Sidak’s multiple comparisons test (seizure index, n = 60 in 3 independent experiments; recovery time, n = 5–16 for TNT) or by Welch’s ANOVA with Dunnett’s multiple comparisons test (recovery time, n = 7–14 for Kir). (D) A working model for the neurometabolic pathway of Indy-dependent seizure suppression.

Discussion

Human genetic studies have previously identified several loss-of-function alleles of ROGDI or SLC13A5 among KTS-associated loci. In the current study, we behaviorally assessed the susceptibility to a specific form of seizure-like activity in Drosophila mutants of the KTS-associated genes. We defined genetic, biochemical, and neural pathways of SLC13A5/Indy-relevant seizure in the context of the citric acid cycle, glutamate metabolism, and glutamatergic transmission (Fig 7D). We further mapped the reversible and scalable functions of the seizure suppressor gene to a surprisingly small group of glutamatergic neurons (i.e., a pair of LHLK neurons) in the adult fly brain. In a broad sense, these findings demonstrate a specific micro-neural circuit that gates both initiation and duration of seizure-like behaviors.

Given the citrate transporter activity of SLC13A5/INDY, it has been suggested that neuronal energy failure may cause SLC13A5-associated epilepsy [7,8]. Citrate acts as a precursor of fatty acid biosynthesis while also serving as a key intermediate in the TCA cycle. Accordingly, an Indy mutation mimics calorie-restricted conditions and thereby causes metabolic and longevity phenotypes in Drosophila and mouse models, including alterations in lipid metabolism (i.e., low-fat storage), insulin signaling, and mitochondrial biogenesis [16,21]. Perturbations of the TCA cycle and altered levels of extracellular TCA metabolites are consistently observed in SLC13A5-associated KTS patients [69]. In fact, genetic losses of other metabolic enzymes involved in the TCA cycle (e.g., IDH3, malate dehydrogenase, fumarase hydratase) have been implicated in several neurological disorders, including early-onset seizure and developmental delay [7074]. Nonetheless, there are conflicting reports on the effects of a ketogenic diet on KTS-associated epilepsy [8].

Genetic or pharmacological manipulations of metabolic enzymes and relevant genes likely impact on general cell physiology. The long-term metabolic stress may thus lead to pleiotropic effects and poor phenotypic outcomes, possibly explaining the seizure phenotypes observed in our genetic models. Nonetheless, several lines of our evidence support a more specific mechanism for Indy-dependent seizure suppression. First, Indy mutants did not display any gross motor defects, while their seizure phenotypes were mapped very specifically to a small group of the glutamatergic LK neurons among other broadly defined groups of neurons (e.g., GABAergic or cholinergic neurons). Second, Indy displayed specific genetic interactions with Idh3, VGlut, and select glutamate receptors on BSS in trans-heterozygous conditions, whereas BSS were not detected in individual heterozygous mutants. Third, genetic enhancement of the glutamate transmission by VGLUT overexpression in LK neurons was sufficient to suppress BSS in INDY-depleted flies. Finally, the INDY-depletion phenotypes were readily reversible in the adult LK neurons (i.e., AKG administration, conditional RNAi) and the optogenetic excitation of INDY-depleted LK neurons only during a mechanical stimulus was sufficient to suppress BSS although the possible off-target effects of the Indy RNAi transgene were not completely excluded. These observations together support our model that impairment of the metabolic flux between the TCA cycle and glutamate biosynthesis—specifically, the conversion of α-ketoglutarate to glutamate—down-scales the seizure-suppressing transmission from a specific subset of glutamatergic neurons, resulting in BSS phenotypes.

Previous studies in animal models have actually implicated low levels of TCA metabolites and glutamate in epilepsy [73,7579]. Moreover, co-injection of α-ketoglutarate suppresses chemically induced epilepsy in mice [80,81], consistent with our results. Intriguingly, the recent observation that α-ketoglutarate promotes the interaction between synaptotagmin 1 and phospholipids demonstrates an unexpected role of α-ketoglutarate in synaptic vesicle fusion [51]. Thus, we reasoned that an excess of α-ketoglutarate might deplete synaptic vesicle pools and thereby interfere with their transmission. This explains why oral administration of α-ketoglutarate to wild-type flies induces rather than suppresses BSS under our experimental conditions.

Although Drosophila genetic studies have led to the isolation and characterization of a number of seizure-related mutants, much less is known about the neural loci responsible for inducing seizure and sustaining seizure-like activity [82]. For instance, the seizure-suppressing function of the potassium-chloride symporter kazachoc and seizure-inducing neural locus in a BSS mutant of the voltage-gated sodium channel paralytic have been mapped to the mushroom body in the adult brain [83,84]. Seizure suppression by the product of the transmembrane domain gene, julius seizure, was more broadly mapped to cholinergic or GABAergic neurons but not to glutamatergic neurons [85]. The emergence of a seizure has been thought to involve three distinct components of neural circuits that mediate seizure initiation, seizure buildup, and seizure spread, respectively [86]. Modulatory neurons likely regulate the excitability of these neural components and thus shape seizure intensity or duration. Based on this model, we propose that glutamatergic LK neurons mediate a seizure-inhibitory pathway such that their conditional silencing de-represses both seizure onset and duration. Accordingly, down-regulation of the glutamatergic transmission from LK neurons induces BSS, as opposed to the general involvement of excitatory glutamate in seizure induction [4446].

Our data suggest that LK signaling is not directly involved in controlling seizure susceptibility, which makes sense considering the temporal scale of neuropeptide signaling in general. Nonetheless, we found that the metabolic flux of the TCA cycle in LK neurons and their glutamate transmission onto dFSB neurons might be closely linked to the control of BSS. Evidence for the involvement of LK neurons in feeding, metabolism, and associated physiology (e.g., circadian behaviors, sleep, memory) is abundant [55,57,6064]. The activity of LHLK neurons is also sensitive to the metabolic state and the time of day [57,60,63]. Thus, we hypothesize that LK neurons act as a neural sensor that integrates internal cues (e.g., circadian clocks, sleep state, and metabolic state) while engaging different postsynaptic partners and divergent pathways for relevant physiological outputs through distinct signaling molecules. In particular, dFSB neurons are a key sleep-promoting locus in the adult fly brain, analogous to the sleep-promoting ventrolateral preoptic nucleus (VLPO) in mammals [87,88]. Given the implication of VLPO in consciousness loss during epileptogenesis [89], the LK-dFSB pathway may reveal the conserved neural principles underlying intimate interactions among metabolism, epilepsy, and sleep [9092].

Drosophila models of human genetic disorders have proven to be valuable tools for elucidating underlying pathogenic mechanisms. Our findings enrich this body of knowledge by providing a genetic, biochemical, and neural map of the seizure suppressor pathway related to KTS. The complexity of the mammalian brain and species-specific organization of excitatory neurotransmitters in the nervous systems may limit the direct relevance of our working model to KTS pathogenesis at neural-circuit levels. Nonetheless, given the strong conservation of SLC13A5/Indy homologs and their physiological function among different species, we propose that similar cellular mechanisms may underlie early-onset seizures in KTS patients and explain their relative resistance to generic antiepileptic drugs.

Materials and methods

Drosophila stocks

All flies were maintained in standard cornmeal–yeast–agar medium at room temperature. w1118 (BL5905; a wild-type control), Indy206 (BL27901), Indy302 (BL27902), Idh3gG9423 (BL30194; CG5028), LkC275 (BL16324), LkrMI06336 (BL41520), LkrMI08640 (BL51094), Nmdar1EP331 (BL17331), Nmdar2attP (BL84548), GluRIAattP (BL84506), GluRIBattP (BL84507), mGluRMI02169(BL32830), GluClαglc1(BL6353), VGlutOK371-Gal4 (BL26160), R23E10-Gal4 (BL49032), VGlut-Gal80 (BL58448), tub-Gal80ts (BL7018), 20XUAS-eNpHR3.0.YFP (BL36350), 20XUAS-IVS-CsChrimson.mVenus (BL55135), 20XUAS-iGluSnFR.A184A (BL59609), UAS-Denmark, UAS-syt.eGFP (BL33065), UAS-Nmdar2RNAi (#1, BL26019), UAS-Nmdar2RNAi (#2, BL40846), 20XUAS-IVS-jGCaMP7f (BL80906), Tdc2[B3RT]-LexA; UAS-B3R, LexAop2-His2B-mCherry, UAS-His2A-GFP (BL91248), and VGlut[B3RT]-LexA (BL91249) were obtained from Bloomington Drosophila Stock Center. UAS-IndyRNAi #1 (3979R-1), UAS-IndyRNAi #2 (3979R-3), UAS-Idh3aRNAi (12233R-3), UAS-Idh3bRNAi (6439R-2), and UAS-Idh3gRNAi (5028R-2) were obtained from National Institute of Genetics. UAS-IndyRNAi #3 (v9981), UAS-IndyRNAi #4 (v9982), UAS-rogdiRNAi (v107310) was obtained from Vienna Drosophila Resource Center. parabss, eas2, and sdaiso7.8 were gifts from Dr. Kitamoto [36] and Dr. Kuebler [37]. VGlut1, VGlut2, and UAS-VGlut were gifts from Dr. DiAntonio [40]. rogdidel, rogdiP1, UAS-rogdi-3xFLAG, UAS-Kir2.1, UAS-TNT, Lk-Gal4, and tsh-Gal80 have been described previously [32,56,67,68,93]. Indy-PB cDNA was PCR-amplified from a cDNA clone (RH67364, Drosophila Genomics Resource Center) and inserted into pUAST-attB-V5 [94]. Subsequently, a T[ACT]>M[ATG] mutation was introduced to the wild-type cDNA to mimic the KTS-associated 680C>T allele. UAS-Indy and UAS-IndyT245M transgenic lines were generated by site-specific transformation on the attP40 landing site (BestGene Inc.)

Bang-sensitive seizure analysis

To avoid any genetic-background effects on bang-sensitive seizure, Indy mutant stocks were outcrossed six times to the wild-type control (w1118) for isogenization. All the behavioral tests for heterozygous, homozygous, and trans-heterozygous mutants were conducted with the isogenized Indy lines and w1118 control. For transgenic lines, seizure behaviors in trans-heterozygous animals were compared to those in all appropriate heterozygous controls. Where applicable, additional transgenic combinations or independent transgenes were tested for validation. Unless otherwise indicated, BSS was assessed in male flies. Three to seven-day-old flies were fed cornmeal–yeast–agar medium in LD cycles at 25°C for 3 d. They were CO2-anesthetized and harvested into fresh vials containing the same food >3 h before a group of flies (n = 5 for non-optogenetic experiments; n = 5–10 for optogenetic experiments) was transferred to an empty vial using an aspirator. Each vial was vortexed at a maximum speed for 25 s using Vortex-Genie 2 (Scientific Industries, Inc.) and then video-recorded for >30 s using a cellular phone (LG G5 Pro or Samsung Galaxy Note 8). BSS-positive flies were defined if they displayed initial paralysis upon mechanical stimulus, followed by uncoordinated movements such as wing-flapping, abdominal contractions, or leg-twitching before their recovery of a normal posture. BSS was quantitatively assessed by three parameters. A seizure index was calculated as the ratio of the number of BSS-positive flies to the total number of flies tested in each experiment (n = ~20 flies per genotype or condition) and averaged from three independent experiments. Recovery time was calculated individually for BSS-positive flies as the latency to normal posture after vortexing and was averaged for each genotype or condition. Percent seizure was calculated as the percentage of BSS-positive flies at each second after vortexing (n = ~60 flies per genotype or condition from all the three experiments). To determine the length of a refractory period in Indy mutants, the first mechanical stimulus was given to each fly and then the second mechanical stimulus was given only to BSS-positive animals at the indicated time after recovery from their first BSS. The seizure index was calculated in each experiment (n = 10 flies per time point) and averaged from three independent experiments.

Locomotor behavior analysis

Locomotor activities in individual male flies were measured in 1-min bins using the Drosophila Activity Monitor system (TriKinetics). Daily locomotor activity (total activity count per 12-hour light: 12-hour dark cycle) and waking activity (averaged activity count per minute awake) were analyzed as described previously [95,96]. For the climbing activity measurement, a group of 10 male flies was kept in the climbing chamber. Flies were allowed to climb for 5 seconds after gentle tapping-down. Climbing distance in each fly was measured as the highest position during the recording.

Oral administration of chemicals

Each chemical was dissolved in 5% sucrose and 2% agar food (behavior food) at the indicated concentration and fed to flies for 3 d before the BSS assessment. The chemicals tested included epigallocatechin gallate (EGCG, Sigma), diethylstilbestrol (DES, Sigma), α-ketoglutarate (Sigma), and KetoCal 4: 1 (fat: carbohydrate plus protein, Nutricia).

Optogenetics

Transgenic flies were grown in light-tight vials and kept in constant dark. They were loaded on to the behavior food containing 0.1 mM all-trans retinal (Sigma) and entrained at 25°C for 3 d. A light source with the indicated wavelength was turned on during the mechanical stimulation. A white LED was covered with a 585-nm or 470-nm filter to generate amber or blue light, respectively, while the 630-nm LED provided red light.

Immunofluorescence imaging

Immunostaining of whole-mount adult brains was performed as described previously [97]. Dissected brains were fixed with 3.7% formaldehyde in PBS, blocked with PBS containing 0.3% Triton X-100 and 5% normal goat serum, and incubated with anti-GFP antibody (Invitrogen, A-11122; diluted at 1:1000) or anti-mCherry antibody (Developmental Studies Hybridoma Bank, DSHB-mCherry-3A11; diluted at 1:20) at 4°C overnight. After washing in PBS containing Triton X-100, immunostained samples were further incubated with species-specific Alexa Fluor secondary antibodies (Jackson ImmunoResearch) at 4°C overnight, washed with PBS containing Triton X-100, and then mounted using VECTASHIELD mounting medium (Vector Laboratories). Confocal images were obtained using an FV1000 microscope (Olympus) and analyzed using ImageJ software.

Live-brain imaging

Transgenic flies were loaded on to the behavior food containing 0 mM (control) or 20 mM α-ketoglutarate (Sigma), entrained at 25°C for 3 d, and then anesthetized in ice. Whole brains were dissected out in hemolymph-like HL3 solution (5 mM HEPES pH 7.2, 70 mM NaCl, 5 mM KCl, 1.5 mM CaCl2, 20 mM MgCl2, 10 mM NaHCO3, 5 mM trehalose, 115 mM sucrose) and then transferred on cover glass in a magnetic imaging chamber (Chamlide CMB, Live Cell Instrument) filled with HL3 buffer. Fluorescence images from live brains were recorded at room temperature using photoactivated localization microscopy (ELYRA P.1, Carl Zeiss) with a C-Apochromat 40x/1.20 W Korr M27 at a pixel resolution of 512 x 512. Fluorescence signals were quantified by background subtraction and analyzed using ZEN software (Carl Zeiss).

Quantitative transcript analysis

Total RNA was purified from thirty fly heads using TRIzol reagent (Thermo Fisher Scientific). After DNase I digestion, cDNA was synthesized using M-MLV Reverse Transcriptase (Promega) and random hexamers. Quantitative real-time PCR was performed using Prime Q-Mastermix (GeNet Bio) and LightCycler 480 Instrument II (Roche). The qPCR primers used in this study were as follows: 5’-TTC ATC GCT TCA CGT CAC TC-3’ (forward) and 5’-TGC TGA CTT GGT GGA TTT TG-3’ (reverse) for rogdi; 5’-ATC TCC CAC AGG ACG TCA AC-3’ (forward) and 5’-GCG ACG AAG AGA AGG ATC AC-3’ (reverse) for pabp (internal control). Indy primers have been described previously [16].

Amino acid profiling

Male flies were loaded on to behavior food containing either 0 mM (control) or 20 mM α-ketoglutarate and then entrained in LD cycles at 25°C for 3 d before harvest. Whole-body extracts were prepared from 50 flies per condition, and the levels of free amino acids were quantitatively measured using ion-exchange chromatography as described previously [95,96].

Metabolite measurements

Whole-body extracts were prepared by homogenizing 8 male flies per sample in 200 μl of PBS containing 0.05% Tween-20. Triglyceride and glucose measurements were performed using Triglyceride Reagent (Sigma-Aldrich, T2449), Free Glycerol Reagent (Sigma-Aldrich, F6428), and Glucose Assay Reagent (Sigma-Aldrich, G3293), respectively, according to the manufacturers’ instructions.

Statistical analysis

Statistical analyses were performed using GraphPad Prism, R (version 3.5.3), or Microsoft Excel. Shapiro-Wilk and Brown-Forsythe tests were conducted to check normality (P < 0.05) and equality of variances (P < 0.05), respectively. For comparisons among multiple samples: 1) Parametric datasets with equal variance were further analyzed by ordinary ANOVA. 2) Parametric datasets with unequal variance were further analyzed by Welch’s ANOVA (one-way) or Aligned ranks transformation ANOVA (two-way). 3) Nonparametric datasets with equal variance were analyzed by Kruskal-Wallis ANOVA (one-way) or Aligned ranks transformation ANOVA (two-way). 4) Nonparametric datasets with unequal variance were analyzed by Aligned ranks transformation ANOVA. Post hoc multiple comparisons were performed by Holm-Sidak’s (ordinary ANOVA), Dunnett’s T3 (Welch’s ANOVA), Wilcoxon rank sum (Aligned ranks transformation ANOVA), or Dunn’s test (Kruskal-Wallis ANOVA). For comparisons between two samples, nonparametric datasets were analyzed by Mann-Whitney U test. Datasets including any sample size less than 7 were analyzed by Student’s t-test or ordinary ANOVA. Sample sizes and P values obtained from individual statistical analyses were indicated in the figure legends.

Supporting information

S1 Fig. Indy mutant flies display BSS comparably to other seizure mutants.

(A) The seizure phenotypes in Indy mutants were comparable to those observed in easily shocked (eas2) and slamdance (sdaiso7.8) but weaker than bang senseless (parabss) mutants. Quantitative analyses of BSS in individual flies were performed as described in Fig 1. Data represent means ± SEM (seizure index, n = 60 flies in 3 independent experiments; recovery time, n = 2–59 flies). n.s., not significant; *P < 0.05, ***P < 0.001, as determined by one-way ANOVA with Holm-Sidak’s multiple comparisons test. (B) Indy mutant seizure displays a refractory period after seizure recovery. The first mechanical stimulus was given to each fly and then the second mechanical stimulus was given only to BSS-positive animals at the indicated time after recovery from their first BSS. The seizure index was calculated in each experiment (n = 10 flies per time point) and averaged from three independent experiments. Error bars indicate SEM.

(TIF)

S2 Fig. Loss of Indy function in specific neurons induces BSS.

(A) Pan-neuronal overexpression of IndyRNAi transgene reduces endogenous Indy expression. Total RNA was purified from fly heads. Quantitative analyses of Indy and poly(A)-binding protein (normalizing control) mRNAs were performed using real-time PCR with gene-specific primer sets. The relative levels of Indy mRNA in each genetic background were calculated by normalizing to Elav>Dcr2 control (set as 1). Data represent means ± SEM (n = 3). ***P < 0.001 as determined by one-way ANOVA with Holm-Sidak’s multiple comparisons test. (B) A genetic screen identifies VGlut- and Lk-expressing neurons as neural loci important for Indy-dependent control of the seizure susceptibility. Quantitative analyses of BSS in individual flies were performed as described in Fig 1. Data represent means ± SEM (n = 60 flies in 3 independent experiments). **P < 0.01, ***P < 0.001, as determined by one-way ANOVA with Holm-Sidak’s multiple comparisons test. (C) The BSS induction by glutamatergic INDY depletion is consistently observed by independent Indy RNAi transgenes. Data represent means ± SEM (seizure index, n = 60 flies in 3 independent experiments; recovery time, n = 1–38 flies). *P < 0.05, **P < 0.01, ***P < 0.001, as determined by one-way ANOVA with Holm-Sidak’s multiple comparisons test.

(TIF)

S3 Fig. Multiple sequence alignment of SLC13A5 homologs reveals the evolutionary conservation of an amino acid residue associated with KTS patients.

Drosophila IndyT245M mutant mimics the gene product of the KTS-associated 680C>T allele. TM, a transmembrane region.

(TIF)

S4 Fig. Loss of rogdi function in glutamatergic neurons induces BSS.

(A) rogdi mutants homozygous or trans-heterozygous for loss-of-function alleles display BSS. Quantitative analyses of BSS in individual flies were performed as described in Fig 1. Data represent means ± SEM. **P < 0.01, ***P < 0.001 as determined by one-way ANOVA with Holm-Sidak’s multiple comparisons test (seizure index, n = 60 flies in 3 independent experiments) or by Aligned ranks transformation ANOVA with Wilcoxon rank sum test (recovery time, n = 7–29 flies). (B) Pan-neuronal overexpression of rogdiRNAi transgene reduces endogenous rogdi expression in fly heads. Quantitative transcript analyses were performed as described in S2A Fig. Data represent means ± SEM (n = 3). ***P < 0.001 as determined by one-way ANOVA with Holm-Sidak’s multiple comparisons test. (C) ROGDI depletion in glutamatergic neurons is sufficient to induce BSS. Quantitative analyses of BSS in individual flies were performed as described in Fig 1. Data represent means ± SEM (seizure index, n = 60 flies in 3 independent experiments; recovery time, n = 5–27 flies). ***P < 0.001, as determined by one-way ANOVA with Holm-Sidak’s multiple comparisons test. (D) Transgenic overexpression of wild-type ROGDI in glutamatergic neurons rescues BSS in rogdi mutants. Data represent means ± SEM (seizure index, n = 49–60 flies in 3 independent experiments; recovery time, n = 6–26 flies). n.s., not significant; **P < 0.01, ***P < 0.001, as determined by two-way ANOVA with Holm-Sidak’s multiple comparisons test.

(TIF)

S5 Fig. Oral administration of the GDH inhibitor diethylstilbestrol (DES) exaggerates BSS phenotypes in Indy mutants.

Flies were fed control or DES-containing food (10 or 20 μg/mg) for 3 d before the BSS assessment. Quantitative analyses of BSS in individual flies were performed as described in Fig 1. Two-way ANOVA detected a significant Indy x DES interaction effect on recovery time (P = 0.0421). Data represent means ± SEM (seizure index, n = 60 flies in 3 independent experiments; recovery time, n = 3–49 flies). n.s., not significant; **P < 0.01, ***P < 0.001, as determined by Holm-Sidak’s multiple comparisons test.

(TIF)

S6 Fig. Depletion of individual IDH3 subunit proteins in glutamatergic neurons induces BSS in a wild-type background.

Quantitative analyses of BSS in individual flies were performed as described in Fig 1. Data represent means ± SEM. **P < 0.01, ***P < 0.001 as determined by one-way ANOVA with Holm-Sidak’s multiple comparisons test (seizure index, n = 60 flies in 3 independent experiments), by Aligned ranks transformation ANOVA with Wilcoxon rank sum test (recovery time, n = 8–43 flies for Idh3aRNAi or Idh3bRNAi), or by Welch’s ANOVA with Dunnett’s T3 multiple comparisons test (recovery time, n = 8–35 flies for Idh3gRNAi).

(TIF)

S7 Fig. Indy mutant flies do not show general motor defects.

(A) w1118 control and Indy mutant flies show similar waking activities under 12-h light: 12-h dark (LD) cycles. Individual male flies were transferred to 65 × 5 mm glass tubes containing 5% sucrose and 2% agar food and entrained in LD cycles. Locomotor activities were indirectly measured by infrared beam crosses per minute using the Drosophila Activity Monitor system. Daily locomotor activity (activity/day) and waking activity (activity/min awake) were calculated in each fly on the fourth LD cycles and averaged (n = 25 and 29 flies for w1118 control and Indy206 mutants, respectively). Error bars indicate SEM. n.s., not significant; *P < 0.05 as determined by Mann-Whitney U test. (B) w1118 control and Indy mutant flies display comparable climbing activities. A group of 10 male flies was kept in the climbing chamber and then allowed to climb for 5 seconds after gentle tapping-down. Climbing distance in each fly was measured as the highest position during the recording and averaged (n = 30). Error bars indicate SEM. n.s., not significant as determined by Student’s t-test.

(TIF)

S8 Fig. Adult LK neurons mediate Indy-dependent BSS.

Adult-specific INDY depletion in LK neurons is sufficient to induce BSS. Transgenic flies were crossed and kept at 21°C to block the expression of IndyRNAi transgene using tub-Gal80ts. Adult flies were then incubated at 21°C (no depletion) or 29°C (RNAi-mediated depletion) for >24 hours prior to the assessment of BSS at the same temperature. Quantitative analyses of BSS in individual flies were performed as described in Fig 1. Data represent means ± SEM (seizure index, n = 60 flies in 3 independent experiments; recovery time, n = 5–28). n.s., not significant; **P < 0.01, ***P < 0.001, as determined by one-way ANOVA with Holm-Sidak’s multiple comparisons test.

(TIF)

S9 Fig. LHLK neurons express the glutamatergic marker gene VGlut.

(A) A transgenic strategy for visualizing VGlut-expressing LK neurons by the fluorescent reporter proteins. The CRISPR-edited VGlut locus includes two B3 recombination target (B3RT) sites upstream of the LexA-coding sequence. LK neuron-specific overexpression of the B3 recombinase leads to the genomic excision, thereby allowing LexA expression only in VGlut-expressing LK neurons. LexA expression could be indirectly visualized by the transgenic mCherry reporter. (B) LHLK neurons, but not SELK neurons, express B3RT-LexA transgene from the VGlut-deleted locus. Representative confocal images of LHLK and SELK neurons in the adult fly brain were shown along with the full genotype.

(TIF)

S10 Fig. IDH3 depletion in LK neurons induces BSS.

Quantitative analyses of BSS in individual flies were performed as described in Fig 1. Data represent means ± SEM (seizure index, n = 44–60 in 3 independent experiments; recovery time, n = 8–27). *P < 0.05, **P < 0.01, ***P < 0.001, as determined by one-way ANOVA with Holm-Sidak’s multiple comparisons test (seizure index), by Aligned ranks transformation ANOVA with Wilcoxon rank sum test (recovery time, Idh3a and Idh3b RNAi), or by Welch’s ANOVA with Dunnett’s multiple comparisons test (recovery time, Idh3g RNAi).

(TIF)

S11 Fig. Indy-relevant seizure unlikely involves metabolic effects.

(A) A lipid-rich diet rescues BSS in eas2 mutants but not in Indy206 mutants. Flies were fed control or 5% KetoCal food for 3 d before the BSS assessment. Quantitative analyses of BSS in individual flies were performed as described in Fig 1. Two-way ANOVA detected a significant eas x KetoCal interaction effect on seizure index (P = 0.0006). Data represent means ± SEM (seizure index, n = 60 flies in 3 independent experiments; recovery time, n = 4–34). n.s., not significant; *P < 0.05, **P < 0.01, ***P < 0.001, as determined by Holm-Sidak’s multiple comparisons test. (B) The lipid-rich diet does not rescue low glucose levels in Indy mutants. Flies were fed control or 5% KetoCal (4: 1 = fat: carbohydrate plus protein) food for 3 d before harvesting. Triglyceride and glucose levels in whole-body extracts were quantified using standard curves. Two-way ANOVA detected significant Indy x KetoCal interaction effects on triglyceride (P = 0.0019) and glucose levels (P = 0.0228). Data represent means ± SEM (n = 5–8). n.s., not significant; *P < 0.05, ***P < 0.001, as determined by Holm-Sidak’s multiple comparisons test. (C) Loss of Indy function in LK neurons does not cause a change in metabolite levels. Data represent means ± SEM (n = 4–5). n.s., not significant as determined by two-way ANOVA with Holm-Sidak’s multiple comparisons test. (D) The lipid-rich diet does not rescue BSS induced by LK neuron-specific loss of Indy function. Two-way ANOVA detected no significant Indy x KetoCal interaction effect on seizure index (P = 0.7802 for IndyRNAi; P = 0.1725 for IndyT245M) and recovery time (P = 0.9534 for IndyRNAi; P = 0.7273 for IndyT245M). n.s., not significant; *P < 0.05, **P < 0.01, ***P < 0.001, as determined by Holm-Sidak’s multiple comparisons test.

(TIF)

S12 Fig. Hypomorphic mutants of Lk and Lkr genes do not display high susceptibility to BSS.

Quantitative analyses of BSS in individual flies were performed as described in Fig 1. Data represent means ± SEM. n.s., not significant; *P < 0.05 as determined by Mann-Whitney U test (seizure index, n = 60 in 3 independent experiments for Lk; recovery time, n = 8–9 flies for Lk) or by one-way ANOVA with Holm-Sidak’s multiple comparisons test (seizure index, n = 54–58 in 3 independent experiments for Lkr; recovery time, n = 4–10 flies for Lkr).

(TIF)

S13 Fig. Optogenetic silencing of LK neurons per se does not induce seizure-like behaviors in the absence of a mechanical stimulus.

Transgenic flies were crossed and kept in constant dark. Any behavioral changes upon exposure to blue (no silencing) or amber light (silencing by eNpHR) condition were examined accordingly. Data represent means ± SEM (seizure index, n = 30 flies in 3 independent experiments; recovery time, n = 2–6 flies). No significant differences in seizure index and recovery time were detected by two-way ANOVA with Holm-Sidak’s multiple comparisons test.

(TIF)

S1 Movie. A video clip for seizure-like behaviors in homozygous Indy206 mutant.

(MP4)

S1 Data. Numerical raw data in Figs 1, 2, 3, 4, 5, 6, and 7, S1, S2, S4, S5, S6, S7, S8, S10, S11, S12 and S13 Figs.

(XLSX)

Acknowledgments

We thank A. DiAntonio, S.J. Certel, D. Dickman, T. Kitamoto, D. Kuebler, R.S. Stowers, Bloomington Drosophila Stock Center, Korea Drosophila Resource Center, National Institute of Genetics, Vienna Drosophila Resource Center, Drosophila Genomics Resource Center, and Developmental Studies Hybridoma Bank for reagents; E.Y. Suh at Chungnam National University for amino acid analyses.

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

This work was supported by grants from the Suh Kyungbae Foundation (SUHF-17020101[CL]); from the National Research Foundation funded by the Ministry of Science and Information & Communication Technology (MSIT), Republic of Korea (NRF-2018R1A5A1024261[CL]; NRF-2021M3A9G8022960[CL]), and by the Ministry of Education, Republic of Korea (NRF-2019R1I1A1A01063087[JL]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Schossig A, Wolf NI, Kapferer I, Kohlschutter A, Zschocke J. Epileptic encephalopathy and amelogenesis imperfecta: Kohlschutter-Tonz syndrome. Eur J Med Genet. 2012;55(5):319–22. doi: 10.1016/j.ejmg.2012.02.008 . [DOI] [PubMed] [Google Scholar]
  • 2.Huckert M, Mecili H, Laugel-Haushalter V, Stoetzel C, Muller J, Flori E, et al. A Novel Mutation in the ROGDI Gene in a Patient with Kohlschutter-Tonz Syndrome. Mol Syndromol. 2014;5(6):293–8. Epub 2015/01/08. doi: 10.1159/000366252 ; PubMed Central PMCID: PMC4281576. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Mory A, Dagan E, Illi B, Duquesnoy P, Mordechai S, Shahor I, et al. A nonsense mutation in the human homolog of Drosophila rogdi causes Kohlschutter-Tonz syndrome. Am J Hum Genet. 2012;90(4):708–14. Epub 2012/04/10. doi: 10.1016/j.ajhg.2012.03.005 ; PubMed Central PMCID: PMC3322231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Mory A, Dagan E, Shahor I, Mandel H, Illi B, Zolotushko J, et al. Kohlschutter-Tonz syndrome: clinical and genetic insights gained from 16 cases deriving from a close-knit village in Northern Israel. Pediatr Neurol. 2014;50(4):421–6. Epub 2014/03/19. doi: 10.1016/j.pediatrneurol.2014.01.006 . [DOI] [PubMed] [Google Scholar]
  • 5.Schossig A, Wolf NI, Fischer C, Fischer M, Stocker G, Pabinger S, et al. Mutations in ROGDI Cause Kohlschutter-Tonz Syndrome. Am J Hum Genet. 2012;90(4):701–7. Epub 2012/03/20. doi: 10.1016/j.ajhg.2012.02.012 ; PubMed Central PMCID: PMC3322220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Tucci A, Kara E, Schossig A, Wolf NI, Plagnol V, Fawcett K, et al. Kohlschutter-Tonz syndrome: mutations in ROGDI and evidence of genetic heterogeneity. Hum Mutat. 2013;34(2):296–300. doi: 10.1002/humu.22241 ; PubMed Central PMCID: PMC3902979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Hardies K, de Kovel CG, Weckhuysen S, Asselbergh B, Geuens T, Deconinck T, et al. Recessive mutations in SLC13A5 result in a loss of citrate transport and cause neonatal epilepsy, developmental delay and teeth hypoplasia. Brain. 2015;138(Pt 11):3238–50. Epub 2015/09/20. doi: 10.1093/brain/awv263 . [DOI] [PubMed] [Google Scholar]
  • 8.Klotz J, Porter BE, Colas C, Schlessinger A, Pajor AM. Mutations in the Na(+)/citrate cotransporter NaCT (SLC13A5) in pediatric patients with epilepsy and developmental delay. Mol Med. 2016;22. Epub 2016/06/05. doi: 10.2119/molmed.2016.00077 ; PubMed Central PMCID: PMC5023510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Thevenon J, Milh M, Feillet F, St-Onge J, Duffourd Y, Juge C, et al. Mutations in SLC13A5 cause autosomal-recessive epileptic encephalopathy with seizure onset in the first days of life. Am J Hum Genet. 2014;95(1):113–20. Epub 2014/07/06. doi: 10.1016/j.ajhg.2014.06.006 ; PubMed Central PMCID: PMC4085634. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Schossig A, Bloch-Zupan A, Lussi A, Wolf NI, Raskin S, Cohen M, et al. SLC13A5 is the second gene associated with Kohlschutter-Tonz syndrome. J Med Genet. 2016. doi: 10.1136/jmedgenet-2016-103988 . [DOI] [PubMed] [Google Scholar]
  • 11.Inoue K, Zhuang L, Maddox DM, Smith SB, Ganapathy V. Structure, function, and expression pattern of a novel sodium-coupled citrate transporter (NaCT) cloned from mammalian brain. J Biol Chem. 2002;277(42):39469–76. Epub 2002/08/15. doi: 10.1074/jbc.M207072200 . [DOI] [PubMed] [Google Scholar]
  • 12.Knauf F, Rogina B, Jiang Z, Aronson PS, Helfand SL. Functional characterization and immunolocalization of the transporter encoded by the life-extending gene Indy. Proc Natl Acad Sci U S A. 2002;99(22):14315–9. Epub 2002/10/23. doi: 10.1073/pnas.222531899 ; PubMed Central PMCID: PMC137881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Rogina B, Reenan RA, Nilsen SP, Helfand SL. Extended life-span conferred by cotransporter gene mutations in Drosophila. Science. 2000;290(5499):2137–40. Epub 2000/12/16. doi: 10.1126/science.290.5499.2137 . [DOI] [PubMed] [Google Scholar]
  • 14.Toivonen JM, Gems D, Partridge L. Longevity of Indy mutant Drosophila not attributable to Indy mutation. Proc Natl Acad Sci U S A. 2009;106(21):E53; author reply E4. Epub 2009/05/14. doi: 10.1073/pnas.0902462106 ; PubMed Central PMCID: PMC2688976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Toivonen JM, Walker GA, Martinez-Diaz P, Bjedov I, Driege Y, Jacobs HT, et al. No influence of Indy on lifespan in Drosophila after correction for genetic and cytoplasmic background effects. PLoS Genet. 2007;3(6):e95. Epub 2007/06/19. doi: 10.1371/journal.pgen.0030095 ; PubMed Central PMCID: PMC1892600. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Wang PY, Neretti N, Whitaker R, Hosier S, Chang C, Lu D, et al. Long-lived Indy and calorie restriction interact to extend life span. Proc Natl Acad Sci U S A. 2009;106(23):9262–7. Epub 2009/05/28. doi: 10.1073/pnas.0904115106 ; PubMed Central PMCID: PMC2685744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Neretti N, Wang PY, Brodsky AS, Nyguyen HH, White KP, Rogina B, et al. Long-lived Indy induces reduced mitochondrial reactive oxygen species production and oxidative damage. Proc Natl Acad Sci U S A. 2009;106(7):2277–82. Epub 2009/01/24. doi: 10.1073/pnas.0812484106 ; PubMed Central PMCID: PMC2629441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Rogers RP, Rogina B. Increased mitochondrial biogenesis preserves intestinal stem cell homeostasis and contributes to longevity in Indy mutant flies. Aging (Albany NY). 2014;6(4):335–50. Epub 2014/05/16. doi: 10.18632/aging.100658 ; PubMed Central PMCID: PMC4032799. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Fei YJ, Liu JC, Inoue K, Zhuang L, Miyake K, Miyauchi S, et al. Relevance of NAC-2, an Na+-coupled citrate transporter, to life span, body size and fat content in Caenorhabditis elegans. Biochem J. 2004;379(Pt 1):191–8. Epub 2003/12/18. doi: 10.1042/BJ20031807 ; PubMed Central PMCID: PMC1224044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Schwarz F, Karadeniz Z, Fischer-Rosinsky A, Willmes DM, Spranger J, Birkenfeld AL. Knockdown of Indy/CeNac2 extends Caenorhabditis elegans life span by inducing AMPK/aak-2. Aging (Albany NY). 2015;7(8):553–67. Epub 2015/09/01. doi: 10.18632/aging.100791 ; PubMed Central PMCID: PMC4586101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Birkenfeld AL, Lee HY, Guebre-Egziabher F, Alves TC, Jurczak MJ, Jornayvaz FR, et al. Deletion of the mammalian INDY homolog mimics aspects of dietary restriction and protects against adiposity and insulin resistance in mice. Cell Metab. 2011;14(2):184–95. Epub 2011/08/02. doi: 10.1016/j.cmet.2011.06.009 ; PubMed Central PMCID: PMC3163140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Brachs S, Winkel AF, Tang H, Birkenfeld AL, Brunner B, Jahn-Hofmann K, et al. Inhibition of citrate cotransporter Slc13a5/mINDY by RNAi improves hepatic insulin sensitivity and prevents diet-induced non-alcoholic fatty liver disease in mice. Mol Metab. 2016;5(11):1072–82. Epub 2016/11/08. doi: 10.1016/j.molmet.2016.08.004 ; PubMed Central PMCID: PMC5081411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Pesta DH, Perry RJ, Guebre-Egziabher F, Zhang D, Jurczak M, Fischer-Rosinsky A, et al. Prevention of diet-induced hepatic steatosis and hepatic insulin resistance by second generation antisense oligonucleotides targeted to the longevity gene mIndy (Slc13a5). Aging (Albany NY). 2015;7(12):1086–93. Epub 2015/12/10. doi: 10.18632/aging.100854 ; PubMed Central PMCID: PMC4712334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Li L, Li H, Garzel B, Yang H, Sueyoshi T, Li Q, et al. SLC13A5 is a novel transcriptional target of the pregnane X receptor and sensitizes drug-induced steatosis in human liver. Mol Pharmacol. 2015;87(4):674–82. Epub 2015/01/30. doi: 10.1124/mol.114.097287 ; PubMed Central PMCID: PMC4366797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Neuschafer-Rube F, Lieske S, Kuna M, Henkel J, Perry RJ, Erion DM, et al. The mammalian INDY homolog is induced by CREB in a rat model of type 2 diabetes. Diabetes. 2014;63(3):1048–57. Epub 2013/11/14. doi: 10.2337/db13-0749 ; PubMed Central PMCID: PMC3968437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Neuschafer-Rube F, Schraplau A, Schewe B, Lieske S, Krutzfeldt JM, Ringel S, et al. Arylhydrocarbon receptor-dependent mIndy (Slc13a5) induction as possible contributor to benzo[a]pyrene-induced lipid accumulation in hepatocytes. Toxicology. 2015;337:1–9. Epub 2015/08/26. doi: 10.1016/j.tox.2015.08.007 . [DOI] [PubMed] [Google Scholar]
  • 27.von Loeffelholz C, Lieske S, Neuschafer-Rube F, Willmes DM, Raschzok N, Sauer IM, et al. The human longevity gene homolog INDY and interleukin-6 interact in hepatic lipid metabolism. Hepatology. 2017;66(2):616–30. Epub 2017/01/31. doi: 10.1002/hep.29089 ; PubMed Central PMCID: PMC5519435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Rogers RP, Rogina B. The role of INDY in metabolism, health and longevity. Front Genet. 2015;6:204. Epub 2015/06/25. doi: 10.3389/fgene.2015.00204 ; PubMed Central PMCID: PMC4460575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Rogina B. INDY-A New Link to Metabolic Regulation in Animals and Humans. Front Genet. 2017;8:66. Epub 2017/06/10. doi: 10.3389/fgene.2017.00066 ; PubMed Central PMCID: PMC5442177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Willmes DM, Kurzbach A, Henke C, Schumann T, Zahn G, Heifetz A, et al. The longevity gene INDY (I’m Not Dead Yet) in metabolic control: Potential as pharmacological target. Pharmacol Ther. 2018;185:1–11. Epub 2017/10/11. doi: 10.1016/j.pharmthera.2017.10.003 . [DOI] [PubMed] [Google Scholar]
  • 31.Dubnau J, Chiang AS, Grady L, Barditch J, Gossweiler S, McNeil J, et al. The staufen/pumilio pathway is involved in Drosophila long-term memory. Curr Biol. 2003;13(4):286–96. Epub 2003/02/21. doi: 10.1016/s0960-9822(03)00064-2 . [DOI] [PubMed] [Google Scholar]
  • 32.Kim M, Jang D, Yoo E, Oh Y, Sonn JY, Lee J, et al. Rogdi Defines GABAergic Control of a Wake-promoting Dopaminergic Pathway to Sustain Sleep in Drosophila. Sci Rep. 2017;7(1):11368. Epub 2017/09/14. doi: 10.1038/s41598-017-11941-3 ; PubMed Central PMCID: PMC5595912. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Riemann D, Wallrafen R, Dresbach T. The Kohlschutter-Tonz syndrome associated gene Rogdi encodes a novel presynaptic protein. Sci Rep. 2017;7(1):15791. Epub 2017/11/19. doi: 10.1038/s41598-017-16004-1 ; PubMed Central PMCID: PMC5693994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Lee H, Jeong H, Choe J, Jun Y, Lim C, Lee C. The crystal structure of human Rogdi provides insight into the causes of Kohlschutter-Tonz Syndrome. Sci Rep. 2017;7(1):3972. Epub 2017/06/24. doi: 10.1038/s41598-017-04120-x ; PubMed Central PMCID: PMC5479863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Parker L, Howlett IC, Rusan ZM, Tanouye MA. Seizure and epilepsy: studies of seizure disorders in Drosophila. Int Rev Neurobiol. 2011;99:1–21. Epub 2011/09/13. doi: 10.1016/B978-0-12-387003-2.00001-X ; PubMed Central PMCID: PMC3532860. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Kasuya J, Iyengar A, Chen HL, Lansdon P, Wu CF, Kitamoto T. Milk-whey diet substantially suppresses seizure-like phenotypes of para(Shu), a Drosophila voltage-gated sodium channel mutant. J Neurogenet. 2019;33(3):164–78. Epub 2019/05/18. doi: 10.1080/01677063.2019.1597082 ; PubMed Central PMCID: PMC6641994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Radlicz C, Chambers A, Olis E, Kuebler D. The addition of a lipid-rich dietary supplement eliminates seizure-like activity and paralysis in the drosophila bang sensitive mutants. Epilepsy Res. 2019;155:106153. Epub 2019/07/02. doi: 10.1016/j.eplepsyres.2019.106153 . [DOI] [PubMed] [Google Scholar]
  • 38.Kuebler D, Tanouye MA. Modifications of seizure susceptibility in Drosophila. J Neurophysiol. 2000;83(2):998–1009. Epub 2000/02/11. doi: 10.1152/jn.2000.83.2.998 . [DOI] [PubMed] [Google Scholar]
  • 39.Selch S, Chafai A, Sticht H, Birkenfeld AL, Fromm MF, Konig J. Analysis of naturally occurring mutations in the human uptake transporter NaCT important for bone and brain development and energy metabolism. Sci Rep. 2018;8(1):11330. Epub 2018/07/29. doi: 10.1038/s41598-018-29547-8 ; PubMed Central PMCID: PMC6063891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Daniels RW, Collins CA, Chen K, Gelfand MV, Featherstone DE, DiAntonio A. A single vesicular glutamate transporter is sufficient to fill a synaptic vesicle. Neuron. 2006;49(1):11–6. Epub 2006/01/03. doi: 10.1016/j.neuron.2005.11.032 ; PubMed Central PMCID: PMC2248602. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Daniels RW, Collins CA, Gelfand MV, Dant J, Brooks ES, Krantz DE, et al. Increased expression of the Drosophila vesicular glutamate transporter leads to excess glutamate release and a compensatory decrease in quantal content. J Neurosci. 2004;24(46):10466–74. Epub 2004/11/19. doi: 10.1523/JNEUROSCI.3001-04.2004 ; PubMed Central PMCID: PMC6730318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Daniels RW, Miller BR, DiAntonio A. Increased vesicular glutamate transporter expression causes excitotoxic neurodegeneration. Neurobiol Dis. 2011;41(2):415–20. Epub 2010/10/19. doi: 10.1016/j.nbd.2010.10.009 ; PubMed Central PMCID: PMC3014407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Steinkellner T, Zell V, Farino ZJ, Sonders MS, Villeneuve M, Freyberg RJ, et al. Role for VGLUT2 in selective vulnerability of midbrain dopamine neurons. J Clin Invest. 2018;128(2):774–88. Epub 2018/01/18. doi: 10.1172/JCI95795 ; PubMed Central PMCID: PMC5785252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Bradford HF. Glutamate, GABA and epilepsy. Prog Neurobiol. 1995;47(6):477–511. Epub 1995/12/01. doi: 10.1016/0301-0082(95)00030-5 . [DOI] [PubMed] [Google Scholar]
  • 45.DiNuzzo M, Mangia S, Maraviglia B, Giove F. Physiological bases of the K+ and the glutamate/GABA hypotheses of epilepsy. Epilepsy Res. 2014;108(6):995–1012. Epub 2014/05/14. doi: 10.1016/j.eplepsyres.2014.04.001 ; PubMed Central PMCID: PMC4838019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Rowley NM, Madsen KK, Schousboe A, Steve White H. Glutamate and GABA synthesis, release, transport and metabolism as targets for seizure control. Neurochem Int. 2012;61(4):546–58. Epub 2012/03/01. doi: 10.1016/j.neuint.2012.02.013 . [DOI] [PubMed] [Google Scholar]
  • 47.Chvilicek MM, Titos I, Rothenfluh A. The Neurotransmitters Involved in Drosophila Alcohol-Induced Behaviors. Front Behav Neurosci. 2020;14:607700. Epub 2021/01/02. doi: 10.3389/fnbeh.2020.607700 ; PubMed Central PMCID: PMC7770116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Kolodziejczyk A, Sun X, Meinertzhagen IA, Nassel DR. Glutamate, GABA and acetylcholine signaling components in the lamina of the Drosophila visual system. PLoS One. 2008;3(5):e2110. Epub 2008/05/10. doi: 10.1371/journal.pone.0002110 ; PubMed Central PMCID: PMC2373871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Liu WW, Wilson RI. Glutamate is an inhibitory neurotransmitter in the Drosophila olfactory system. Proc Natl Acad Sci U S A. 2013;110(25):10294–9. Epub 2013/06/05. doi: 10.1073/pnas.1220560110 ; PubMed Central PMCID: PMC3690841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Li C, Allen A, Kwagh J, Doliba NM, Qin W, Najafi H, et al. Green tea polyphenols modulate insulin secretion by inhibiting glutamate dehydrogenase. J Biol Chem. 2006;281(15):10214–21. Epub 2006/02/16. doi: 10.1074/jbc.M512792200 . [DOI] [PubMed] [Google Scholar]
  • 51.Ugur B, Bao H, Stawarski M, Duraine LR, Zuo Z, Lin YQ, et al. The Krebs Cycle Enzyme Isocitrate Dehydrogenase 3A Couples Mitochondrial Metabolism to Synaptic Transmission. Cell Rep. 2017;21(13):3794–806. Epub 2017/12/28. doi: 10.1016/j.celrep.2017.12.005 ; PubMed Central PMCID: PMC5747319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Gargano JW, Martin I, Bhandari P, Grotewiel MS. Rapid iterative negative geotaxis (RING): a new method for assessing age-related locomotor decline in Drosophila. Exp Gerontol. 2005;40(5):386–95. Epub 2005/05/28. doi: 10.1016/j.exger.2005.02.005 . [DOI] [PubMed] [Google Scholar]
  • 53.Marden JH, Rogina B, Montooth KL, Helfand SL. Conditional tradeoffs between aging and organismal performance of Indy long-lived mutant flies. Proc Natl Acad Sci U S A. 2003;100(6):3369–73. Epub 2003/03/11. doi: 10.1073/pnas.0634985100 ; PubMed Central PMCID: PMC152299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Martin I, Grotewiel MS. Distinct genetic influences on locomotor senescence in Drosophila revealed by a series of metrical analyses. Exp Gerontol. 2006;41(9):877–81. Epub 2006/08/08. doi: 10.1016/j.exger.2006.06.052 . [DOI] [PubMed] [Google Scholar]
  • 55.Al-Anzi B, Armand E, Nagamei P, Olszewski M, Sapin V, Waters C, et al. The leucokinin pathway and its neurons regulate meal size in Drosophila. Curr Biol. 2010;20(11):969–78. Epub 2010/05/25. doi: 10.1016/j.cub.2010.04.039 ; PubMed Central PMCID: PMC2896026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.de Haro M, Al-Ramahi I, Benito-Sipos J, Lopez-Arias B, Dorado B, Veenstra JA, et al. Detailed analysis of leucokinin-expressing neurons and their candidate functions in the Drosophila nervous system. Cell Tissue Res. 2010;339(2):321–36. Epub 2009/11/27. doi: 10.1007/s00441-009-0890-y . [DOI] [PubMed] [Google Scholar]
  • 57.Yurgel ME, Kakad P, Zandawala M, Nassel DR, Godenschwege TA, Keene AC. A single pair of leucokinin neurons are modulated by feeding state and regulate sleep-metabolism interactions. PLoS Biol. 2019;17(2):e2006409. Epub 2019/02/14. doi: 10.1371/journal.pbio.2006409 ; PubMed Central PMCID: PMC6391015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Sherer LM, Catudio Garrett E, Morgan HR, Brewer ED, Sirrs LA, Shearin HK, et al. Octopamine neuron dependent aggression requires dVGLUT from dual-transmitting neurons. PLoS Genet. 2020;16(2):e1008609. Epub 2020/02/26. doi: 10.1371/journal.pgen.1008609 ; PubMed Central PMCID: PMC7059954. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Marvin JS, Borghuis BG, Tian L, Cichon J, Harnett MT, Akerboom J, et al. An optimized fluorescent probe for visualizing glutamate neurotransmission. Nat Methods. 2013;10(2):162–70. Epub 2013/01/15. doi: 10.1038/nmeth.2333 ; PubMed Central PMCID: PMC4469972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Cavey M, Collins B, Bertet C, Blau J. Circadian rhythms in neuronal activity propagate through output circuits. Nat Neurosci. 2016;19(4):587–95. Epub 2016/03/02. doi: 10.1038/nn.4263 ; PubMed Central PMCID: PMC5066395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Murakami K, Yurgel ME, Stahl BA, Masek P, Mehta A, Heidker R, et al. translin Is Required for Metabolic Regulation of Sleep. Curr Biol. 2016;26(7):972–80. Epub 2016/03/30. doi: 10.1016/j.cub.2016.02.013 ; PubMed Central PMCID: PMC4846466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Murphy KR, Deshpande SA, Yurgel ME, Quinn JP, Weissbach JL, Keene AC, et al. Postprandial sleep mechanics in Drosophila. Elife. 2016;5. Epub 2016/11/23. doi: 10.7554/eLife.19334 ; PubMed Central PMCID: PMC5119887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Senapati B, Tsao CH, Juan YA, Chiu TH, Wu CL, Waddell S, et al. A neural mechanism for deprivation state-specific expression of relevant memories in Drosophila. Nat Neurosci. 2019;22(12):2029–39. Epub 2019/10/30. doi: 10.1038/s41593-019-0515-z ; PubMed Central PMCID: PMC6885014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Zandawala M, Yurgel ME, Texada MJ, Liao S, Rewitz KF, Keene AC, et al. Modulation of Drosophila post-feeding physiology and behavior by the neuropeptide leucokinin. PLoS Genet. 2018;14(11):e1007767. Epub 2018/11/21. doi: 10.1371/journal.pgen.1007767 ; PubMed Central PMCID: PMC6245514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Klapoetke NC, Murata Y, Kim SS, Pulver SR, Birdsey-Benson A, Cho YK, et al. Independent optical excitation of distinct neural populations. Nat Methods. 2014;11(3):338–46. Epub 2014/02/11. doi: 10.1038/nmeth.2836 ; PubMed Central PMCID: PMC3943671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Petersen LK, Stowers RS. A Gateway MultiSite recombination cloning toolkit. PLoS One. 2011;6(9):e24531. Epub 2011/09/21. doi: 10.1371/journal.pone.0024531 ; PubMed Central PMCID: PMC3170369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Baines RA, Uhler JP, Thompson A, Sweeney ST, Bate M. Altered electrical properties in Drosophila neurons developing without synaptic transmission. J Neurosci. 2001;21(5):1523–31. Epub 2001/02/27. doi: 10.1523/JNEUROSCI.21-05-01523.2001 ; PubMed Central PMCID: PMC6762927. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Sweeney ST, Broadie K, Keane J, Niemann H, O’Kane CJ. Targeted expression of tetanus toxin light chain in Drosophila specifically eliminates synaptic transmission and causes behavioral defects. Neuron. 1995;14(2):341–51. Epub 1995/02/01. doi: 10.1016/0896-6273(95)90290-2 . [DOI] [PubMed] [Google Scholar]
  • 69.Bainbridge MN, Cooney E, Miller M, Kennedy AD, Wulff JE, Donti T, et al. Analyses of SLC13A5-epilepsy patients reveal perturbations of TCA cycle. Mol Genet Metab. 2017;121(4):314–9. Epub 2017/07/05. doi: 10.1016/j.ymgme.2017.06.009 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Ait-El-Mkadem S, Dayem-Quere M, Gusic M, Chaussenot A, Bannwarth S, Francois B, et al. Mutations in MDH2, Encoding a Krebs Cycle Enzyme, Cause Early-Onset Severe Encephalopathy. Am J Hum Genet. 2017;100(1):151–9. Epub 2016/12/19. doi: 10.1016/j.ajhg.2016.11.014 ; PubMed Central PMCID: PMC5223029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Fattal-Valevski A, Eliyahu H, Fraenkel ND, Elmaliach G, Hausman-Kedem M, Shaag A, et al. Homozygous mutation, p.Pro304His, in IDH3A, encoding isocitrate dehydrogenase subunit is associated with severe encephalopathy in infancy. Neurogenetics. 2017;18(1):57–61. Epub 2017/01/07. doi: 10.1007/s10048-016-0507-z . [DOI] [PubMed] [Google Scholar]
  • 72.Kovac S, Abramov AY, Walker MC. Energy depletion in seizures: anaplerosis as a strategy for future therapies. Neuropharmacology. 2013;69:96–104. Epub 2012/06/05. doi: 10.1016/j.neuropharm.2012.05.012 . [DOI] [PubMed] [Google Scholar]
  • 73.McDonald T, Puchowicz M, Borges K. Impairments in Oxidative Glucose Metabolism in Epilepsy and Metabolic Treatments Thereof. Front Cell Neurosci. 2018;12:274. Epub 2018/09/21. doi: 10.3389/fncel.2018.00274 ; PubMed Central PMCID: PMC6127311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Ottolenghi C, Hubert L, Allanore Y, Brassier A, Altuzarra C, Mellot-Draznieks C, et al. Clinical and biochemical heterogeneity associated with fumarase deficiency. Hum Mutat. 2011;32(9):1046–52. Epub 2011/05/12. doi: 10.1002/humu.21534 . [DOI] [PubMed] [Google Scholar]
  • 75.Alvestad S, Hammer J, Eyjolfsson E, Qu H, Ottersen OP, Sonnewald U. Limbic structures show altered glial-neuronal metabolism in the chronic phase of kainate induced epilepsy. Neurochem Res. 2008;33(2):257–66. Epub 2007/08/22. doi: 10.1007/s11064-007-9435-5 . [DOI] [PubMed] [Google Scholar]
  • 76.Melo TM, Nehlig A, Sonnewald U. Metabolism is normal in astrocytes in chronically epileptic rats: a (13)C NMR study of neuronal-glial interactions in a model of temporal lobe epilepsy. J Cereb Blood Flow Metab. 2005;25(10):1254–64. Epub 2005/05/20. doi: 10.1038/sj.jcbfm.9600128 . [DOI] [PubMed] [Google Scholar]
  • 77.Smeland OB, Hadera MG, McDonald TS, Sonnewald U, Borges K. Brain mitochondrial metabolic dysfunction and glutamate level reduction in the pilocarpine model of temporal lobe epilepsy in mice. J Cereb Blood Flow Metab. 2013;33(7):1090–7. Epub 2013/04/25. doi: 10.1038/jcbfm.2013.54 ; PubMed Central PMCID: PMC3705438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Fergestad T, Bostwick B, Ganetzky B. Metabolic disruption in Drosophila bang-sensitive seizure mutants. Genetics. 2006;173(3):1357–64. Epub 2006/05/02. doi: 10.1534/genetics.106.057463 ; PubMed Central PMCID: PMC1526683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Jakkamsetti V, Marin-Valencia I, Ma Q, Good LB, Terrill T, Rajasekaran K, et al. Brain metabolism modulates neuronal excitability in a mouse model of pyruvate dehydrogenase deficiency. Sci Transl Med. 2019;11(480). Epub 2019/02/23. doi: 10.1126/scitranslmed.aan0457 ; PubMed Central PMCID: PMC6637765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Yamamoto H. Protection against cyanide-induced convulsions with alpha-ketoglutarate. Toxicology. 1990;61(3):221–8. Epub 1990/04/30. doi: 10.1016/0300-483x(90)90172-d . [DOI] [PubMed] [Google Scholar]
  • 81.Yamamoto HA, Mohanan PV. Effect of alpha-ketoglutarate and oxaloacetate on brain mitochondrial DNA damage and seizures induced by kainic acid in mice. Toxicol Lett. 2003;143(2):115–22. Epub 2003/05/17. doi: 10.1016/s0378-4274(03)00114-0 . [DOI] [PubMed] [Google Scholar]
  • 82.Saras A, Simon LE, Brawer HJ, Price RE, Tanouye MA. Drosophila seizure disorders: genetic suppression of seizure susceptibility. Frontiers in Biology. 2016;11(2):96–108. doi: 10.1007/s11515-016-1395-1 [DOI] [Google Scholar]
  • 83.Hekmat-Scafe DS, Mercado A, Fajilan AA, Lee AW, Hsu R, Mount DB, et al. Seizure sensitivity is ameliorated by targeted expression of K+-Cl- cotransporter function in the mushroom body of the Drosophila brain. Genetics. 2010;184(1):171–83. Epub 2009/11/04. doi: 10.1534/genetics.109.109074 ; PubMed Central PMCID: PMC2815914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Saras A, Wu VV, Brawer HJ, Tanouye MA. Investigation of Seizure-Susceptibility in a Drosophila melanogaster Model of Human Epilepsy with Optogenetic Stimulation. Genetics. 2017;206(4):1739–46. Epub 2017/06/21. doi: 10.1534/genetics.116.194779 ; PubMed Central PMCID: PMC5560784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Horne M, Krebushevski K, Wells A, Tunio N, Jarvis C, Francisco G, et al. julius seizure, a Drosophila Mutant, Defines a Neuronal Population Underlying Epileptogenesis. Genetics. 2017;205(3):1261–9. Epub 2017/01/14. doi: 10.1534/genetics.116.199083 ; PubMed Central PMCID: PMC5340337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Bertram EH. Neuronal circuits in epilepsy: do they matter? Exp Neurol. 2013;244:67–74. Epub 2012/02/22. doi: 10.1016/j.expneurol.2012.01.028 ; PubMed Central PMCID: PMC4266595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Liu Q, Liu S, Kodama L, Driscoll MR, Wu MN. Two dopaminergic neurons signal to the dorsal fan-shaped body to promote wakefulness in Drosophila. Curr Biol. 2012;22(22):2114–23. Epub 2012/10/02. doi: 10.1016/j.cub.2012.09.008 ; PubMed Central PMCID: PMC3505250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Donlea JM, Pimentel D, Talbot CB, Kempf A, Omoto JJ, Hartenstein V, et al. Recurrent Circuitry for Balancing Sleep Need and Sleep. Neuron. 2018;97(2):378–89 e4. Epub 2018/01/09. doi: 10.1016/j.neuron.2017.12.016 ; PubMed Central PMCID: PMC5779612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Feng M, He Z, Liu B, Li Z, Tao G, Wu D, et al. Consciousness loss during epileptogenesis: implication for VLPO-PnO circuits. Int J Physiol Pathophysiol Pharmacol. 2017;9(1):1–7. Epub 2017/03/25. ; PubMed Central PMCID: PMC5344992. [PMC free article] [PubMed] [Google Scholar]
  • 90.Jin B, Aung T, Geng Y, Wang S. Epilepsy and Its Interaction With Sleep and Circadian Rhythm. Front Neurol. 2020;11:327. Epub 2020/05/28. doi: 10.3389/fneur.2020.00327 ; PubMed Central PMCID: PMC7225332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Lucey BP, Leahy A, Rosas R, Shaw PJ. A new model to study sleep deprivation-induced seizure. Sleep. 2015;38(5):777–85. Epub 2014/12/18. doi: 10.5665/sleep.4674 ; PubMed Central PMCID: PMC4402675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Petruccelli E, Lansdon P, Kitamoto T. Exaggerated Nighttime Sleep and Defective Sleep Homeostasis in a Drosophila Knock-In Model of Human Epilepsy. PLoS One. 2015;10(9):e0137758. Epub 2015/09/12. doi: 10.1371/journal.pone.0137758 ; PubMed Central PMCID: PMC4567262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Clyne JD, Miesenbock G. Sex-specific control and tuning of the pattern generator for courtship song in Drosophila. Cell. 2008;133(2):354–63. Epub 2008/04/22. doi: 10.1016/j.cell.2008.01.050 . [DOI] [PubMed] [Google Scholar]
  • 94.Lim C, Allada R. ATAXIN-2 activates PERIOD translation to sustain circadian rhythms in Drosophila. Science. 2013;340(6134):875–9. Epub 2013/05/21. doi: 10.1126/science.1234785 . [DOI] [PubMed] [Google Scholar]
  • 95.Ki Y, Lim C. Sleep-promoting effects of threonine link amino acid metabolism in Drosophila neuron to GABAergic control of sleep drive. Elife. 2019;8. Epub 2019/07/18. doi: 10.7554/eLife.40593 ; PubMed Central PMCID: PMC6636906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Sonn JY, Lee J, Sung MK, Ri H, Choi JK, Lim C, et al. Serine metabolism in the brain regulates starvation-induced sleep suppression in Drosophila melanogaster. Proc Natl Acad Sci U S A. 2018;115(27):7129–34. Epub 2018/06/20. doi: 10.1073/pnas.1719033115 ; PubMed Central PMCID: PMC6142195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Lee J, Yoo E, Lee H, Park K, Hur JH, Lim C. LSM12 and ME31B/DDX6 Define Distinct Modes of Posttranscriptional Regulation by ATAXIN-2 Protein Complex in Drosophila Circadian Pacemaker Neurons. Mol Cell. 2017;66(1):129–40 e7. Epub 2017/04/08. doi: 10.1016/j.molcel.2017.03.004 . [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Gaiti Hasan, Gregory P Copenhaver

27 Apr 2021

Dear Dr Lim,

Thank you very much for submitting your Research Article entitled 'Metabolic flux from the Krebs cycle to glutamate transmission tunes a neural brake on seizure onset' to PLOS Genetics.

The manuscript was fully evaluated at the editorial level and by independent peer reviewers. The reviewers appreciated the attention to an important problem, but raised some substantial concerns about the current manuscript. Based on the reviews, we will not be able to accept this version of the manuscript, but we would be willing to review a much-revised version. We cannot, of course, promise publication at that time.

Should you decide to revise the manuscript for further consideration here, your revisions should address the specific points made by each reviewer. We will also require a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript.

If you decide to revise the manuscript for further consideration at PLOS Genetics, please aim to resubmit within the next 60 days, unless it will take extra time to address the concerns of the reviewers, in which case we would appreciate an expected resubmission date by email to plosgenetics@plos.org.

If present, accompanying reviewer attachments are included with this email; please notify the journal office if any appear to be missing. They will also be available for download from the link below. You can use this link to log into the system when you are ready to submit a revised version, having first consulted our Submission Checklist.

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Please be aware that our data availability policy requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as "data not shown" or "unpublished results" in manuscripts. All points should be backed up by data provided with the submission.

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool.  PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

PLOS has incorporated Similarity Check, powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.

To resubmit, use the link below and 'Revise Submission' in the 'Submissions Needing Revision' folder.

[LINK]

We are sorry that we cannot be more positive about your manuscript at this stage. Please do not hesitate to contact us if you have any concerns or questions.

Yours sincerely,

Gaiti Hasan

Associate Editor

PLOS Genetics

Gregory P. Copenhaver

Editor-in-Chief

PLOS Genetics

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: The Drosophila Indy gene encodes a fly homolog of the mammalian SLC13A5 citrate transporter. In this study, Jeong et al. found that loss-of-function Indy mutants displayed seizure-like behaviors in response to strong mechanical disturbances. Based on the experimental results obtained using genetic, optogenetic, and pharmacological approaches, the authors concluded that this behavioral abnormality of Indy mutants are caused by defective glutamate synthesis and glutamatergic transmission in the lateral horn leucokinin (LHLK) neurons, innervating the fan-shaped body. This is a carefully done study and findings are novel and interesting. In particular, it is surprising that, although Indy is expressed widely, seizure behaviors of the mutants are attributable to reduced Indy function in a specific pair of glutamatergic neurons in the brain (LHLK neurons).

Several points need clarifying and certain statements require further justification.

A number of Drosophila “bang-sensitive” mutants (i.e., mutants with increased susceptibility to seizures following mechanical stimulation) have been identified. Some of them (e.g., easily shocked, bang senseless, and slamdance) have been extensively studied. Are the “bang-induced” seizure-like behaviors observed in Indy mutants similar to or different from the known bang-sensitive phenotypes? This is the first time that Indy mutants’ bang-induced phenotype is described. Please describe the phenotype in more detail in the context of other bang-sensitive phenotypes. It would be useful if a video clip showing the representative phenotype would be included in the supplemental information or a schematic figure describing the behavioral sequence could be shown (e.g., Fig. 1 in Howlett et al. (2013) for para[bss1]).

Unlike mammals, Drosophila uses glutamate, instead of acetylcholine, as an excitatory neurotransmitter for motor neurons. The authors claim that reduced Indy function in glutamatergic neurons leads to suppression of glutamatergic transmission. It is expected that motor neurons in Indy mutants are suboptimal and that the mutants display defects in motor neuron physiology and motor behavior. Please refer to relevant previous studies, if any, that are consistent with the proposed effects of Indy loss-of-function on glutamatergic neurons.

In Indy mutants and VGlu-Gal4 mediated Indy knockdown flies, motor neurons are defective due to suppression of glutamatergic neurotransmission. In contrast, motor neurons are fully functional in the flies with Lk-Gal4 mediated Indy knockdown. When the bang sensitivity is increased due to reduced Indy function in LHLK neurons, I expect that the latter flies (Lk-Gal4 mediated Indy knockdown) display more severe seizures compared to the former flies (Indy mutants and VGlu-Gal4 mediated Indy knockdown flies) because of the difference in motor activity. However, the bang-sensitive seizure-like phenotypes are similar in these flies (Figs. 1B, 2B, and 5A). Any explanation?

Various Gal4 lines, including NP and R-lines, were used in a Gal4 mini screen (S1 Fig). Please indicate their specificity (tissue or cell type), if known, in the supporting information.

Knockdown of Indy in glutamatergic neurons leads to an increased sensitivity to bang-induced seizures. How specific is this behavioral phenotype to Indy knockdown in glutamatergic neurons? Indy knockdown in cholinergic, GABAergic, or serotonergic neurons does not have any effect? Do the NP- and R-lines used in this study include Gal4 lines driving Indy-RNAi expression in neuronal subsets other than glutamatergic neurons?

Page 2, 2nd paragraph: It’s not appropriate to call mouse SLC13A5 INDY.

Page 4, the 1st sentence: “Glutamate and GABA are two major neurotransmitters that mediate transmission at excitatory and inhibitory synapses, respectively”. In flies, they are acetylcholine and GABA, respectively.

S4B Fig: Describe how the experiment was done.

Reviewer #2: Overall recommendation: Accept with revisions

In this well-controlled and interesting manuscript, Jeong et al find that knockdown or knockout of Indy, the Drosophila homologue of a gene implicated in a human seizure disorder, causes a bang-sensitive seizure behavior in flies. They then outline a mechanism by which losing Indy function leads to decreased TCA cycle activity and associated glutamate production, which acts as the primary cellular mechanism underpinning the bang-sensitive seizure susceptibility. Screening for neurons that can recapitulate this global phenotype, they then discover a set of neurons that seem to be responsible for gating the Indy¬-associated bang-sensitive phenotype and further map aspects of a preliminary neural circuit for bang-sensitive seizures. This circuit mechanism is bolstered with both genetic knockouts/knockdowns and optogenetic manipulation. Together, then, this manuscript establishes two interesting findings: it uncovers a potential cellular mechanism for a disease-causing mutation in humans and outlines the beginnings of a novel neural circuit governing a bang-sensitive seizure phenotype in flies. The manuscript is clearly written and the experiments robust and well-controlled and will likely prove interesting to a wide audience.

Major Concerns

1). The authors use single cell data from another publication to demonstrate that there is evidence of glutamatergic signaling machinery in LK neurons. This data as presented seems to rely on a single cell in the database that expresses both LK and VGlut, which could be correctly identifying the studied neurons or could easily be due to statistical randomness. Given the fact that this claim goes against the assumptions of the field, it would be more convincing to provide staining, in situ hybridization, or tagged protein localization evidence of Vglut in these LK neurons. Additionally, more information on how the single-cell data was visualized and manipulated should be included in the methods section if this data is retained in the final manuscript.

2) The manipulation of GDH appears to this Reviewer to be an especially critical experiment as it serves as a clear link between TCA metabolism and glutamate transmission (as opposed to other downstream effects of TCA metabolism such as cell health). Therefore, I would find it extra convincing for the phenotype demonstrated using epigallocatechin gallate feeding to be recapitulated with a temperature sensitive RNAi or similar genetic approach. Alternatively, if GDH overexpression suppressed the effect of the GDH inhibitor in a cell-specific fashion this would also add certainty to that result.

3) The assumption of many experiments involving VGlut overexpression appears to be that overexpressing VGlut will compensate for lower levels of glutamate by increasing synaptic loading. Because the authors already have the capacity for GluSnFr visualization as shown later in the manuscript, it would be compelling to show that VGlut overexpression leads to greater extracellular glutamate release in the Indy-RNAi background, as such an experiment would argue against alternative changes in glutamate/glutamine cycling induced by VGlut overexpression.

4) The authors use a bang-sensitive protocol that is different from most other labs - they vortex for 25 second (long) versus 10 seconds (normal), and the "seizures" are much shorter--they observe ~20 seconds versus 1-2 minutes in bang-sensitive mutants. Is this really seizure? There is no electrophysiology to address that. In addition, the pathway they have chosen to explore and many of the manipulations would be expected to have serious consequences on metabolism (e.g. TCA cycle)...is it possible that rather than siezure this is an energy deficiency? Are there controls they could do to address this?

Minor Concerns

• The paper introduces both Indy and rogdi as Drosophila homologues of Kohlschütter-Tönz syndrome and mentions both in the introduction and discussion. However, while a small amount of compelling evidence is presented in the supplements that a similar mechanism links rogdi and indy loss-of-function to this seizure model, the vast majority of the mechanistic characterization of the manuscript focuses on indy and thus the extent of discussion of rogdi in the introduction appears somewhat speculative.

• The labels of Figure 2c are difficult to read. I fully understand the authors’ decision to only have one set of x-axis labels to save space, but the complexity of the x-axis labels makes it very difficult to understand the upper graph.

• The authors refer to depleting INDY expression – only Indy transcripts can change in expression, INDY protein should change in abundance (if this is indeed what is indicated by the change in nomenclature here)

• Several times the authors use “On the other hand” in the context of information that is logically consistent with the previous sentence, which confused me as this phrase traditionally introduces information that is contradictory to the previous sentiment in some way.

• Removal of the word “the” before metabolic challenge in the introduction.

• I would like the praise the authors for not attempting to statistically analyze the curves of seizure behavior over time in addition to seizure index and recovery time as such analysis quickly get statistically dubious.

Reviewer #3: In the manuscript titled “Metabolic flux from the Krebs cycle to glutamate transmission tunes a neural brake on seizure onset”, Jeong et al. show that mutations in the citrate transporter gene Indy can lead to bang-sensitive seizures in Drosophila. Based on extensive genetic data, they propose a model which suggest that Indy affects glutamate metabolism in a pair of glutamatergic neurons, which act as an excitatory break on the onset of more generalized seizures. This is a well-written manuscript, which provides diverse empirical evidence for the proposed model. However, several concerns about data robustness and experimental approach require additional clarifications. Below are comments that I hope the authors will find useful:

1. The mechanistic model proposed here is based on possibly interesting Drosophila data. However, its true relevance to the early-onset of seizures in KTS might be overstated. The authors should make it clear to the readers that in contrast to the mammalian brain, the primary excitatory neurotransmitter in the fly brain is acetylcholine, not glutamate. Instead, glutamate plays a key role as the primary excitatory neurotransmitter at the fly’s NMJ. Therefore, if the link between the TCA cycle and neuronal glutamate metabolism is conserved across the fly and human nervous systems then one might expect the effects of Indy mutations to lead to higher seizure threshold relative to wild type animals.

2. Some of the data presented in the supplementary figures is confusing. For example, the authors use the pan-neuronal elav-GAL4 driver to show that the Indy RNAi transgene is effective in reducing Indy mRNA levels. Yet, the elav>Indy-RNAi F1 flies show no seizure hypersensitivity. It is puzzling why the authors did not also include the well-established GAL4 drivers for GABAergic and cholinergic neurons. Did the author include UAS-Dcr transgene in all their focal crosses?

3. Linking metabolism to hyperexcitability and other aspects of neuronal physiology is always difficult because demonstrating specificity of genetic and pharmacological manipulations on phenotype, especially when it is measured at the organismal level, is almost impossible. The authors should acknowledge this in their introduction and discussion, and should address the many possible mechanistic confounds related to their proposed interpretation of the data. For example, long-term knockdown of Indy in any cell type will lead to physiological stress, and poor phenotypic outcomes

4. One major issue with the experimental design as described in the methods is that the authors may have not addressed some the known issues with strong effect of genetic background on bang-sensitivity. No specific information for most GAL4 lines used for the screen shown in Fig. S1, or what was the specific genetic background of control RNAi animals is not provided. Furthermore, the specific RNAi line used by the authors in their screen is pupal lethal when broadly expressed, and has been discarded by the NIG due to off-target effects, and no longer available.

5. If five flies were used in each trial bang-sensitivity trial, the lowest % recovery possible at any given time point is 20% (1/5 flies). Therefore, it is puzzling how it is possible to have values below 20% in Fig. 1. Furthermore, since each recovering fly represents 20% of the population, it is confusing why the curves seem to describe continuous data.

6. Previous studies have indicated that measuring seizure thresholds shifts during the refractory period between bang-induced seizures is a more robust measure of the effects of genotype on seizure sensitivity (e.g., Kuebler and Tanouye, J Neurophys 2000).

7. In my opinion, the most important, and somewhat surprising data presented here is included in the section titled “A pair of glutamatergic neurons mediates Indy-dependent seizure suppression”. However, as written, this section is very confusing, and the rational for the testing the hypothesis that Indy is particularly important in “LK” neurons, and what might be the relationship between these neuropeptidergic neurons and the glutamatergic system is not explained or justified. Furthermore, the rationale for the genetic scheme used, how the various tools used specifically address the key questions, and how the approach could help separating developmental versus physiological effects of Indy knockdown, are impossible to follow.

8. The detailed info about the ROGDI gene in the introduction is not really relevant to the main focus of the current paper.

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: No: Couldn't find the raw behavioral data.

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Marc Freeman

Reviewer #3: No

Decision Letter 1

Gaiti Hasan, Gregory P Copenhaver

5 Oct 2021

Dear Dr Lim,

Thank you very much for submitting your Research Article entitled 'Metabolic flux from the Krebs cycle to glutamate transmission tunes a neural brake on seizure onset' to PLOS Genetics.

The manuscript was fully evaluated at the editorial level and by independent peer reviewers. The reviewers appreciated the attention to an important topic but identified some concerns that we ask you address in a revised manuscript

We therefore ask you to modify the manuscript according to the review recommendations. Your revisions should address the specific points made by each reviewer.

In addition we ask that you:

1) Provide a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript.

2) Upload a Striking Image with a corresponding caption to accompany your manuscript if one is available (either a new image or an existing one from within your manuscript). If this image is judged to be suitable, it may be featured on our website. Images should ideally be high resolution, eye-catching, single panel square images. For examples, please browse our archive. If your image is from someone other than yourself, please ensure that the artist has read and agreed to the terms and conditions of the Creative Commons Attribution License. Note: we cannot publish copyrighted images.

We hope to receive your revised manuscript within the next 30 days. If you anticipate any delay in its return, we would ask you to let us know the expected resubmission date by email to plosgenetics@plos.org.

If present, accompanying reviewer attachments should be included with this email; please notify the journal office if any appear to be missing. They will also be available for download from the link below. You can use this link to log into the system when you are ready to submit a revised version, having first consulted our Submission Checklist.

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Please be aware that our data availability policy requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as "data not shown" or "unpublished results" in manuscripts. All points should be backed up by data provided with the submission.

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

PLOS has incorporated Similarity Check, powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.

To resubmit, you will need to go to the link below and 'Revise Submission' in the 'Submissions Needing Revision' folder.

[LINK]

Please let us know if you have any questions while making these revisions.

Yours sincerely,

Gaiti Hasan

Associate Editor

PLOS Genetics

Gregory P. Copenhaver

Editor-in-Chief

PLOS Genetics

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: The authors have conducted additional experiments, provided new data, and revised the text appropriately in response to most of the comments made by reviewers. Although it is not clear why the seizure-suppressing activity of LHLK neurons are particularly sensitive to reduced glutamatergic transmission, and why their dysfunction induces seizure-like behavior, this study has set the foundation for future investigation of a novel neural circuit governing a bang-sensitive phenotype as well as potential genetic interactions between Indy and other bang-sensitive mutants.

“Seizure-like behaviors, including wing-flapping and abdomen-twitching, were scored in individual flies throughout the recorded video clip”. It’s still not clear to me exactly how seizures are defined. The fly in the video clip displays neither wing-flapping nor abdomen-twitching. Initial paralysis, loss of posture, and uncoordinated leg movements are also considered “seizure”? Please explain.

Reviewer #2: The authors have done a good job of addressing my concerns. I have no remaining concerns and think this will be a nice addition to PLoS-Genetics.

Reviewer #3: The revised manuscripts is significantly improved. One possibly minor issue that was not addressed in the revision relates to the specific Indy UAS-RNAi line used and it's possible off-target effects. This is particularly important because the transgenic line used in this study is no longer available from public sources, which potentially would make it difficult to replicate the studies by others.

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

Decision Letter 2

Gaiti Hasan, Gregory P Copenhaver

11 Oct 2021

Dear Dr Lim,

We are pleased to inform you that your manuscript entitled "Metabolic flux from the Krebs cycle to glutamate transmission tunes a neural brake on seizure onset" has been editorially accepted for publication in PLOS Genetics. Congratulations!

Before your submission can be formally accepted and sent to production you will need to complete our formatting changes, which you will receive in a follow up email. Please be aware that it may take several days for you to receive this email; during this time no action is required by you. Please note: the accept date on your published article will reflect the date of this provisional acceptance, but your manuscript will not be scheduled for publication until the required changes have been made.

Once your paper is formally accepted, an uncorrected proof of your manuscript will be published online ahead of the final version, unless you’ve already opted out via the online submission form. If, for any reason, you do not want an earlier version of your manuscript published online or are unsure if you have already indicated as such, please let the journal staff know immediately at plosgenetics@plos.org.

In the meantime, please log into Editorial Manager at https://www.editorialmanager.com/pgenetics/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production and billing process. Note that PLOS requires an ORCID iD for all corresponding authors. Therefore, please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field.  This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.

If you have a press-related query, or would like to know about making your underlying data available (as you will be aware, this is required for publication), please see the end of this email. If your institution or institutions have a press office, please notify them about your upcoming article at this point, to enable them to help maximise its impact. Inform journal staff as soon as possible if you are preparing a press release for your article and need a publication date.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Genetics!

Yours sincerely,

Gaiti Hasan

Associate Editor

PLOS Genetics

Gregory P. Copenhaver

Editor-in-Chief

PLOS Genetics

www.plosgenetics.org

Twitter: @PLOSGenetics

----------------------------------------------------

Comments from the reviewers (if applicable):

----------------------------------------------------

Data Deposition

If you have submitted a Research Article or Front Matter that has associated data that are not suitable for deposition in a subject-specific public repository (such as GenBank or ArrayExpress), one way to make that data available is to deposit it in the Dryad Digital Repository. As you may recall, we ask all authors to agree to make data available; this is one way to achieve that. A full list of recommended repositories can be found on our website.

The following link will take you to the Dryad record for your article, so you won't have to re‐enter its bibliographic information, and can upload your files directly: 

http://datadryad.org/submit?journalID=pgenetics&manu=PGENETICS-D-21-00356R2

More information about depositing data in Dryad is available at http://www.datadryad.org/depositing. If you experience any difficulties in submitting your data, please contact help@datadryad.org for support.

Additionally, please be aware that our data availability policy requires that all numerical data underlying display items are included with the submission, and you will need to provide this before we can formally accept your manuscript, if not already present.

----------------------------------------------------

Press Queries

If you or your institution will be preparing press materials for this manuscript, or if you need to know your paper's publication date for media purposes, please inform the journal staff as soon as possible so that your submission can be scheduled accordingly. Your manuscript will remain under a strict press embargo until the publication date and time. This means an early version of your manuscript will not be published ahead of your final version. PLOS Genetics may also choose to issue a press release for your article. If there's anything the journal should know or you'd like more information, please get in touch via plosgenetics@plos.org.

Acceptance letter

Gaiti Hasan, Gregory P Copenhaver

15 Oct 2021

PGENETICS-D-21-00356R2

Metabolic flux from the Krebs cycle to glutamate transmission tunes a neural brake on seizure onset

Dear Dr Lim,

We are pleased to inform you that your manuscript entitled "Metabolic flux from the Krebs cycle to glutamate transmission tunes a neural brake on seizure onset" has been formally accepted for publication in PLOS Genetics! Your manuscript is now with our production department and you will be notified of the publication date in due course.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript.

Soon after your final files are uploaded, unless you have opted out or your manuscript is a front-matter piece, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting PLOS Genetics and open-access publishing. We are looking forward to publishing your work!

With kind regards,

Zsofia Freund

PLOS Genetics

On behalf of:

The PLOS Genetics Team

Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom

plosgenetics@plos.org | +44 (0) 1223-442823

plosgenetics.org | Twitter: @PLOSGenetics

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Indy mutant flies display BSS comparably to other seizure mutants.

    (A) The seizure phenotypes in Indy mutants were comparable to those observed in easily shocked (eas2) and slamdance (sdaiso7.8) but weaker than bang senseless (parabss) mutants. Quantitative analyses of BSS in individual flies were performed as described in Fig 1. Data represent means ± SEM (seizure index, n = 60 flies in 3 independent experiments; recovery time, n = 2–59 flies). n.s., not significant; *P < 0.05, ***P < 0.001, as determined by one-way ANOVA with Holm-Sidak’s multiple comparisons test. (B) Indy mutant seizure displays a refractory period after seizure recovery. The first mechanical stimulus was given to each fly and then the second mechanical stimulus was given only to BSS-positive animals at the indicated time after recovery from their first BSS. The seizure index was calculated in each experiment (n = 10 flies per time point) and averaged from three independent experiments. Error bars indicate SEM.

    (TIF)

    S2 Fig. Loss of Indy function in specific neurons induces BSS.

    (A) Pan-neuronal overexpression of IndyRNAi transgene reduces endogenous Indy expression. Total RNA was purified from fly heads. Quantitative analyses of Indy and poly(A)-binding protein (normalizing control) mRNAs were performed using real-time PCR with gene-specific primer sets. The relative levels of Indy mRNA in each genetic background were calculated by normalizing to Elav>Dcr2 control (set as 1). Data represent means ± SEM (n = 3). ***P < 0.001 as determined by one-way ANOVA with Holm-Sidak’s multiple comparisons test. (B) A genetic screen identifies VGlut- and Lk-expressing neurons as neural loci important for Indy-dependent control of the seizure susceptibility. Quantitative analyses of BSS in individual flies were performed as described in Fig 1. Data represent means ± SEM (n = 60 flies in 3 independent experiments). **P < 0.01, ***P < 0.001, as determined by one-way ANOVA with Holm-Sidak’s multiple comparisons test. (C) The BSS induction by glutamatergic INDY depletion is consistently observed by independent Indy RNAi transgenes. Data represent means ± SEM (seizure index, n = 60 flies in 3 independent experiments; recovery time, n = 1–38 flies). *P < 0.05, **P < 0.01, ***P < 0.001, as determined by one-way ANOVA with Holm-Sidak’s multiple comparisons test.

    (TIF)

    S3 Fig. Multiple sequence alignment of SLC13A5 homologs reveals the evolutionary conservation of an amino acid residue associated with KTS patients.

    Drosophila IndyT245M mutant mimics the gene product of the KTS-associated 680C>T allele. TM, a transmembrane region.

    (TIF)

    S4 Fig. Loss of rogdi function in glutamatergic neurons induces BSS.

    (A) rogdi mutants homozygous or trans-heterozygous for loss-of-function alleles display BSS. Quantitative analyses of BSS in individual flies were performed as described in Fig 1. Data represent means ± SEM. **P < 0.01, ***P < 0.001 as determined by one-way ANOVA with Holm-Sidak’s multiple comparisons test (seizure index, n = 60 flies in 3 independent experiments) or by Aligned ranks transformation ANOVA with Wilcoxon rank sum test (recovery time, n = 7–29 flies). (B) Pan-neuronal overexpression of rogdiRNAi transgene reduces endogenous rogdi expression in fly heads. Quantitative transcript analyses were performed as described in S2A Fig. Data represent means ± SEM (n = 3). ***P < 0.001 as determined by one-way ANOVA with Holm-Sidak’s multiple comparisons test. (C) ROGDI depletion in glutamatergic neurons is sufficient to induce BSS. Quantitative analyses of BSS in individual flies were performed as described in Fig 1. Data represent means ± SEM (seizure index, n = 60 flies in 3 independent experiments; recovery time, n = 5–27 flies). ***P < 0.001, as determined by one-way ANOVA with Holm-Sidak’s multiple comparisons test. (D) Transgenic overexpression of wild-type ROGDI in glutamatergic neurons rescues BSS in rogdi mutants. Data represent means ± SEM (seizure index, n = 49–60 flies in 3 independent experiments; recovery time, n = 6–26 flies). n.s., not significant; **P < 0.01, ***P < 0.001, as determined by two-way ANOVA with Holm-Sidak’s multiple comparisons test.

    (TIF)

    S5 Fig. Oral administration of the GDH inhibitor diethylstilbestrol (DES) exaggerates BSS phenotypes in Indy mutants.

    Flies were fed control or DES-containing food (10 or 20 μg/mg) for 3 d before the BSS assessment. Quantitative analyses of BSS in individual flies were performed as described in Fig 1. Two-way ANOVA detected a significant Indy x DES interaction effect on recovery time (P = 0.0421). Data represent means ± SEM (seizure index, n = 60 flies in 3 independent experiments; recovery time, n = 3–49 flies). n.s., not significant; **P < 0.01, ***P < 0.001, as determined by Holm-Sidak’s multiple comparisons test.

    (TIF)

    S6 Fig. Depletion of individual IDH3 subunit proteins in glutamatergic neurons induces BSS in a wild-type background.

    Quantitative analyses of BSS in individual flies were performed as described in Fig 1. Data represent means ± SEM. **P < 0.01, ***P < 0.001 as determined by one-way ANOVA with Holm-Sidak’s multiple comparisons test (seizure index, n = 60 flies in 3 independent experiments), by Aligned ranks transformation ANOVA with Wilcoxon rank sum test (recovery time, n = 8–43 flies for Idh3aRNAi or Idh3bRNAi), or by Welch’s ANOVA with Dunnett’s T3 multiple comparisons test (recovery time, n = 8–35 flies for Idh3gRNAi).

    (TIF)

    S7 Fig. Indy mutant flies do not show general motor defects.

    (A) w1118 control and Indy mutant flies show similar waking activities under 12-h light: 12-h dark (LD) cycles. Individual male flies were transferred to 65 × 5 mm glass tubes containing 5% sucrose and 2% agar food and entrained in LD cycles. Locomotor activities were indirectly measured by infrared beam crosses per minute using the Drosophila Activity Monitor system. Daily locomotor activity (activity/day) and waking activity (activity/min awake) were calculated in each fly on the fourth LD cycles and averaged (n = 25 and 29 flies for w1118 control and Indy206 mutants, respectively). Error bars indicate SEM. n.s., not significant; *P < 0.05 as determined by Mann-Whitney U test. (B) w1118 control and Indy mutant flies display comparable climbing activities. A group of 10 male flies was kept in the climbing chamber and then allowed to climb for 5 seconds after gentle tapping-down. Climbing distance in each fly was measured as the highest position during the recording and averaged (n = 30). Error bars indicate SEM. n.s., not significant as determined by Student’s t-test.

    (TIF)

    S8 Fig. Adult LK neurons mediate Indy-dependent BSS.

    Adult-specific INDY depletion in LK neurons is sufficient to induce BSS. Transgenic flies were crossed and kept at 21°C to block the expression of IndyRNAi transgene using tub-Gal80ts. Adult flies were then incubated at 21°C (no depletion) or 29°C (RNAi-mediated depletion) for >24 hours prior to the assessment of BSS at the same temperature. Quantitative analyses of BSS in individual flies were performed as described in Fig 1. Data represent means ± SEM (seizure index, n = 60 flies in 3 independent experiments; recovery time, n = 5–28). n.s., not significant; **P < 0.01, ***P < 0.001, as determined by one-way ANOVA with Holm-Sidak’s multiple comparisons test.

    (TIF)

    S9 Fig. LHLK neurons express the glutamatergic marker gene VGlut.

    (A) A transgenic strategy for visualizing VGlut-expressing LK neurons by the fluorescent reporter proteins. The CRISPR-edited VGlut locus includes two B3 recombination target (B3RT) sites upstream of the LexA-coding sequence. LK neuron-specific overexpression of the B3 recombinase leads to the genomic excision, thereby allowing LexA expression only in VGlut-expressing LK neurons. LexA expression could be indirectly visualized by the transgenic mCherry reporter. (B) LHLK neurons, but not SELK neurons, express B3RT-LexA transgene from the VGlut-deleted locus. Representative confocal images of LHLK and SELK neurons in the adult fly brain were shown along with the full genotype.

    (TIF)

    S10 Fig. IDH3 depletion in LK neurons induces BSS.

    Quantitative analyses of BSS in individual flies were performed as described in Fig 1. Data represent means ± SEM (seizure index, n = 44–60 in 3 independent experiments; recovery time, n = 8–27). *P < 0.05, **P < 0.01, ***P < 0.001, as determined by one-way ANOVA with Holm-Sidak’s multiple comparisons test (seizure index), by Aligned ranks transformation ANOVA with Wilcoxon rank sum test (recovery time, Idh3a and Idh3b RNAi), or by Welch’s ANOVA with Dunnett’s multiple comparisons test (recovery time, Idh3g RNAi).

    (TIF)

    S11 Fig. Indy-relevant seizure unlikely involves metabolic effects.

    (A) A lipid-rich diet rescues BSS in eas2 mutants but not in Indy206 mutants. Flies were fed control or 5% KetoCal food for 3 d before the BSS assessment. Quantitative analyses of BSS in individual flies were performed as described in Fig 1. Two-way ANOVA detected a significant eas x KetoCal interaction effect on seizure index (P = 0.0006). Data represent means ± SEM (seizure index, n = 60 flies in 3 independent experiments; recovery time, n = 4–34). n.s., not significant; *P < 0.05, **P < 0.01, ***P < 0.001, as determined by Holm-Sidak’s multiple comparisons test. (B) The lipid-rich diet does not rescue low glucose levels in Indy mutants. Flies were fed control or 5% KetoCal (4: 1 = fat: carbohydrate plus protein) food for 3 d before harvesting. Triglyceride and glucose levels in whole-body extracts were quantified using standard curves. Two-way ANOVA detected significant Indy x KetoCal interaction effects on triglyceride (P = 0.0019) and glucose levels (P = 0.0228). Data represent means ± SEM (n = 5–8). n.s., not significant; *P < 0.05, ***P < 0.001, as determined by Holm-Sidak’s multiple comparisons test. (C) Loss of Indy function in LK neurons does not cause a change in metabolite levels. Data represent means ± SEM (n = 4–5). n.s., not significant as determined by two-way ANOVA with Holm-Sidak’s multiple comparisons test. (D) The lipid-rich diet does not rescue BSS induced by LK neuron-specific loss of Indy function. Two-way ANOVA detected no significant Indy x KetoCal interaction effect on seizure index (P = 0.7802 for IndyRNAi; P = 0.1725 for IndyT245M) and recovery time (P = 0.9534 for IndyRNAi; P = 0.7273 for IndyT245M). n.s., not significant; *P < 0.05, **P < 0.01, ***P < 0.001, as determined by Holm-Sidak’s multiple comparisons test.

    (TIF)

    S12 Fig. Hypomorphic mutants of Lk and Lkr genes do not display high susceptibility to BSS.

    Quantitative analyses of BSS in individual flies were performed as described in Fig 1. Data represent means ± SEM. n.s., not significant; *P < 0.05 as determined by Mann-Whitney U test (seizure index, n = 60 in 3 independent experiments for Lk; recovery time, n = 8–9 flies for Lk) or by one-way ANOVA with Holm-Sidak’s multiple comparisons test (seizure index, n = 54–58 in 3 independent experiments for Lkr; recovery time, n = 4–10 flies for Lkr).

    (TIF)

    S13 Fig. Optogenetic silencing of LK neurons per se does not induce seizure-like behaviors in the absence of a mechanical stimulus.

    Transgenic flies were crossed and kept in constant dark. Any behavioral changes upon exposure to blue (no silencing) or amber light (silencing by eNpHR) condition were examined accordingly. Data represent means ± SEM (seizure index, n = 30 flies in 3 independent experiments; recovery time, n = 2–6 flies). No significant differences in seizure index and recovery time were detected by two-way ANOVA with Holm-Sidak’s multiple comparisons test.

    (TIF)

    S1 Movie. A video clip for seizure-like behaviors in homozygous Indy206 mutant.

    (MP4)

    S1 Data. Numerical raw data in Figs 1, 2, 3, 4, 5, 6, and 7, S1, S2, S4, S5, S6, S7, S8, S10, S11, S12 and S13 Figs.

    (XLSX)

    Attachment

    Submitted filename: ResponseToReviewerComments - JeongLim2021.docx

    Attachment

    Submitted filename: ResponseToReviewerComments - 2ndRev.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS Genetics are provided here courtesy of PLOS

    RESOURCES